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1 FUNCTIONAL DNA IN SCIENTIFIC RESEARCH 
 
DNA (deoxyribonucleic acid) besides being the genetic material of living organisms has arisen as 
a very important macromolecule in various fields of science due to its noteworthy properties. The 
reason for using DNA in applications lies in its self-assembly potential through hydrogen bonding 
between nucleobases and its well-defined, predictable topology. The preparation of DNA for 
scientific purposes requires chemical modifications on its native structure. The ability to rapidly 
synthesize any desired DNA sequence by automated solid-phase methods makes it possible to 
prepare chemically modified oligonucleotides. This chapter gives firstly an overview of the 
structure and properties of natural DNA followed by outlining the application of DNA as a 
versatile molecule in different fields of science. Finally, the possible chemical modifications in 
order to bring new functions to DNA are discussed. The modifications on the backbone of the 








1.1 THE STRUCTURE AND FUNCTION OF DNA  
The structure of DNA was discovered and published in 1953 with a great impact in biology by 
R. FRANKLIN, M. WILKINS, J. WATSON and F. CRICK.[1] This pioneering work led using DNA in various 
applications, more importantly in the field of molecular biology in initial phase. The defined 
structure of DNA is composed of two heteropolymer strands which are coiled around a common 
axis in an antiparallel fashion in the form of a double helix. Individual single strands consist of 
four different monomeric units which are termed as nucleotides. Each nucleotidic unit is 
composed of a sugar, a heterocyclic base and a phosphate group (Fig. 1a). Furthermore, the 
heterocyclic bases can be classified into pyrimidine derivatives (thymine T and cytosine C) and 
purine derivatives (adenine A and guanine G) (Fig. 1b). The nucleotide monomers are linked to 
each other by phosphodiester bonds between 3'- hydroxyl group (3'- OH) of the one nucleotide 
and 5'- hydroxyl group (5'- OH) of the adjacent one to form the sugar-phosphate backbone. The 
sugar-phosphate backbone is on the outside and the bases lie on the inside of the helix. The two 
single strands of the double helix are held together through hydrogen bonding between 
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Figure 1: Building blocks of nucleic acid. a) Structure of the nucleotide monomers, 2'-deoxyguanosine dG, 
2'-deoxyadenosine dA, 2'-deoxythymidine dT, 2'-deoxycytidine dC. b) Structure of four natural DNA 
nucleobases, Guanine G, adenine A, thymine T, cytosine C. c) Watson-Crick base-pairing in an antiparallel 
fashion.  
 
The hydrogen bonded base-pairs that stabilize DNA double helix is termed as Watson-Crick 
base-pairing. The base-pairing process occurs in a specific manner such that the guanine residue 
on one strand always pairs with cytosine on the other strand and likewise the adenine residue 
always pairs with the thymine residue. There are three hydrogen bonds in GC base-pairs and two 
hydrogen bonds in AT base-pairs (Fig. 1c). This pairing of nucleobases is known as 
complementary base-pairing and the two single strands are complementary to each other. Thus, 




Apart from hydrogen bonding, the double helix is largely stabilized by stacking interactions 
between π-orbitals of the planar aromatic rings of the bases.[2,3] Hydrophobic and electrostatic 
interactions lead to the stacking interactions. The overall stability of the double helix is 
significantly conserved by stacking. The factors behind stacking such as hydrophobicity, stacking 
area, polarisability of the bases, overall dipole moment and overlap between bases contribute to 
an increase in the double helix stability.[4–6]  
 
1.1.1 REPLICATION AND PROTEIN SYNTHESIS AS DNA-TEMPLATED REACTIONS  
 
The DNA macromolecule is the carrier of the genetic information in all living cells. The genetic 
information is coded in the sequence of the heterocyclic bases. Before cell division, DNA 
transfers this information to a copy of itself in a process known as DNA replication. The 
mechanism for this great task is provided by its highly ordered double helix structure. After the 
discovery of the DNA double helix it was realized that the process of DNA replication involves a 
templated synthesis. During DNA replication, the double helix structure is unzipped and 
unwound. This provides two partially single strands where the bases are exposed to the 
surroundings. The both unwound strands act as template for the preparation of two new 
daughter strands. Each incoming free deoxynucleotide triphosphate (dNTP) pairs through 
hydrogen bonding with its complementary base on the original unwound template strand (Fig. 
2). As the dNTP pairs with its complementary base, its nucleophilic 3'-OH group reacts with the 
5'-(α) phosphate of an incoming dNTP and the DNA chain grows. An enzyme, DNA polymerase, 
catalyzes the phosphodiester formation reaction but only if the base of the incoming dNTP is 




























































































































































































Figure 2: Model representation of DNA replication. Nucleotide triphosphates (dNTP) are monomers of 
DNA polymerization reaction and compose of a deoxyribose sugar, three phosphates and one of the four 
nucleobases. Each nucleotide is selected through base-pairing and joined together from 5'- to 3'- direction 
as shown on the upper strand. 
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Thus, DNA polymerase is a template-directed enzyme that synthesizes a product with a base 
sequence complementary to that of the template. The new strands are synthesized in 5'- to 3'- 
direction.[7]  
Template-directed reaction also takes place in protein synthesis which is the second 
fundamental task of DNA. There are two main stages in the production of proteins; transcription 
and translation. Transcription is responsible for transferring the genetic information coded in 
DNA into an RNA molecule. In the transcription process part of the DNA double helix is unzipped 
which is aided by an enzyme. Once the DNA is unwound, the bases are exposed and can be used 
as a template for the formation of mRNA, analogous to DNA replication process. Once the DNA 
bases are exposed, free ribonucleotide triphosphates (rNTP) can bind to the exposed DNA bases 
by complementary base-pairing. RNA polymerase catalyses the formation of hydrogen bonds 
between the complementary DNA-RNA bases, as well as catalysing the growth of the RNA 
strand. The free rNTP are converted to ribonucleotide monophospates (rNMP) as they are added 
to the growing RNA molecule. The pyrophosphate side product is again formed during mRNA 
formation. The second stage of protein synthesis translates the genetic code contained in mRNA 




1.2 USING DNA IN SCIENCE AND TECHNOLOGY 
Beside its traditional importance in life, DNA has become an attractive macromolecule in 
scientific research due to its outstanding properties. (i) Self-assembly: Two single stranded 
oligonucleotides (both complementary to each other) in solution assemble spontaneously into 
double helical structure through specific base-pairing. (ii) Geometry and Topology: DNA has a 
very predictable geometry and well-stacked antiparallel double helix structure due to base-
pairing rule. The outer diameter of the helical structure of B-DNA (the width of DNA) is 2 nm. 
The individual base-pairs are stacked with a distance of 0.34 nm and one helical turn is 3.4-3.6 
nm.[8,9] Geometry of double helix depends on the properties of the solution such as salt and 
organic solvent concentration. The DNA double helix can form conformations other than B-DNA 
such as A- or Z-DNA. Besides forming a double helix, DNA assembles to more complex tertiary 
structures as well. DNA is able to fold into three-dimensional structures. For instance a single 
stranded DNA after 150 bp starts to behave as a worm-like polymer chain. If its ends come to 
close proximity, they can bond together and form circular supercoiled DNA. The geometry and 
topology of DNA is controllable and programmable which is an useful tool for the construction of 
two- and three- dimensional nanostructures.[10]  
DNA is initially used in biological applications such as hybridization probes, DNA linkers, primers 
for PCR technique, antisense or antigene therapy and fluorescent labeling.[11–14] It is also used for 
many interesting nonbiological applications. It has become a versatile molecule, particularly 
attractive in nanotechnology. This field of science aims to use self-assembly potential of DNA not 
only for formation of double helix but also for construction of highly structured materials from 
DNA.[8,15,16] Well-defined double helical structure can be precisely controlled and programmed 
for the design of DNA-based architectures. Applications of DNA as scaffold for preparing 
supramolecular arrays as sensors, computational element, molecular switches, nano-wires, 
nano-pictures have been reported elsewhere.[17,18] Apart from its applications in biology and 
nanotechnology scientists have recognized the potential of DNA in chemical applications.[19] Task 
of DNA in chemical reactions could be as a template or as a direct/indirect catalyst.[20–22] 
The use of DNA for all above mentioned applications often requires changes in the chemical 
structure of natural DNA. If some functional organic or inorganic molecules are incorporated into 
DNA with fluorescent,[23] electrical and magnetic[24,25] and/or metal ion binding properties, it 
might adopt a completely new structure and new function beyond its limits. In this manner 
functionalized DNA exhibit novel properties such as fluorescence emission, catalytic activity 
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and/or ability to carry metal ions. The utilization of DNA in a various fields of science has 
increased significantly with the development of automated DNA synthesis. 
 
1.2.1 THE CHEMICAL SYNTHESIS OF OLIGONUCLEOTIDES 
 
To synthesize oligonucleotides basically two different approaches are feasible: the enzymatic 



























Figure  3 : a) Schematic representation of polymerase chain reaction (or  primer extension reaction). b) 
DMT-Protected phosphoramidite monomer which is necessary for the synthesis of oligonucleotides 
through automated DNA synthesizer.  PB = Protected Base.  
 
Enzymatic DNA synthesis by DNA polymerases 
The enzymatic synthesis of DNA is termed as polymerase chain reactions.[26] In this process, the 
nucleotide monomers are applied as 5’-triphosphate derivatives. The DNA polymerase catalyses 
the template-directed elongation of the primer DNA strand by incorporation of nucleotides 
(Fig. 3a).  
 
Automated DNA Synthesis by DNA Synthesizers 
Nowadays it is possible to synthesize any desired sequence of oligonucleotide (up to 
approximately 100-nt) with or without modifications in moderate time and yield through DNA 
synthesizer. By DNA synthesizer, principally, the nucleoside monomers are sequentially coupled 
through phosphodiester linkage by elongating the oligonucleotide polymer which is bound on a 
solid support. For the synthesis of the oligonucleotides, first the monomeric building blocks are 
chemically synthesized and then the monomers are coupled via DNA synthesizer. 
The natural nucleosides are not sufficiently reactive for a coupling reaction between two 
monomers to form a phosphodiester linkage. Therefore, the more reactive 3'- phosphoramidite 
derivatives (Fig. 3b) are used as building blocks for automated solid phase oligonucleotide 
synthesis.[27] 3'-OH of the nucleosides are converted to the more reactive 
N,N-diisopropylphosphoramidite group where the 5'-OH of the same nucleoside is protected by 
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using the acid labile 4,4'-dimethoxytrityl (DMT) group to prevent undesired reactions during the 
synthesis. Furthermore, exocyclic amino groups present on the nucleobases should also be 
protected; examples are acetyl (Ac) for cytosine, benzoyl (Bz) for adenine, dimethylformamide 
(Dmf) for guanine. Phosphoramidite monomers of unmodified natural nucleosides are 
commercially available whereas the nucleosides carrying the modifications need to be 
chemically synthesized.  
Once the phosphoramidite derivative of the desired nucleoside with or without modifications is 





1.3 CHEMICAL MODIFICATIONS OF DNA 
Chemical modification of DNA represents the attachment of new functional molecules such as 
fluorescent dyes, intercalating agents, metal complexes or a displaceable leaving group at an 
appropriate section of the oligonucleotide. In initial studies, functional molecules were tethered 
to the 3'- or more commonly 5'- backbone ends.[28–33] In addition to 3'- and 5'- ends, the 
functional molecules can also be introduced within the strand.[34] A monomeric unit of an 
oligonucleotide composed of a sugar, a nucleobase and a phosphate backbone, each of these 

















Figure 4: Chemical modification sites of a nucleotide monomer; on nucleobase, on sugar moiety or on 
phosphate groups.  
 
1.3.1  MODIFICATIONS ON NUCLEOBASES 
 
The modifications on nucleobases can be placed at pre-determined positions in helically 
structured duplexes. When the functional molecule is aimed to be placed in the major groove of 
the double helix C-5 of a pyrimidine base or C-8 of a purine base are sites of choice 
(Fig. 5a, b).[39,40] C-7 Modified 7-deazapurine analogs are also possible for modifications pointing 
towards the major groove. (Fig. 5c).[41] Modifications at these positions do not disturb Watson-
Crick base-pairing. Modification is not only the attachment but also can be removal of a 
complete nucleobase moiety. Nucleobase moieties have been replaced with unnatural 
molecules such as simple heterocycles, hydrocarbons, metal-binding ligands or shape mimics of 
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Figure 5 : Selected modifications on different labeling positions on nucleobases for internal modifications. 
a) Thymidine analog with new functional group on nucleobase C-5 position.[39] b) Guanosine analogue with 
new functional group on nucleobase C-8 position.[40] c) 7-Deaza adenosine analogue with new functional 
group on nucleobase C-7 position.[41] d) Ligandoside where nucleobase moiety is completely replaced with 
a metal-binding ligand.[42]  
 
1.3.2  MODIFICATIONS ON SUGAR MOIETY 
 
Modifications on the sugar moiety by varying the substituents generate oligomers which are 
containing sugars other than deoxyribose. There are different possibilities for covalent 
modifications of the sugar. The ribose ring has a free site at C-2' position at which different 
moieties can be attached (Fig. 6a). C-2' Position of the sugar moiety is suitable when a structural 
modification in the minor groove is desired.[34,43] The utilization of ribose instead of deoxyribose 
is easier for modification at C-2'.[44–47] Substitution of the oxygen in the ribose ring with sulfur 
and nitrogen or use of a hexose instead of pentose as sugar portion are examples for 
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Figure  6 : Selected modifications on sugar moieties by varying the substituents b) Modifications on C-2` 
position of a ribose which carry two bases.[46] b) Substitution of the oxygen atom on the ribose with a 
sulfur atom.[49] c) Use of a  hexose instead of pentose as modifications.[48] 
 
1.3.3 MODIFICATIONS ON PHOSPHATE GROUP 
 
Chemical modifications on the backbone can be performed by varying the substituent of the 
phosphate group of the nucleotide. Modification of the phosphodiester linkage is possible 
through automated DNA synthesis.[50] The phosphate group can be modified by replacing one of 
the oxygens with a different substituent (Fig. 7). The first chemically synthesized 
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oligonucleotides were methylphosphonates where the non-bridging oxygen was replaced with a 
methyl group at each phosphorous atom on the oligonucleotide chain (Fig. 7a). Although those 
olignucleotides are highly stable in biological systems, the absence of charge on the backbone 
reduces its solubility. Methylphosphonate linkages are also inherently helix-destabilizing. 
Phosphorothioates where the non-bridging oxygen atom was replaced with a sulfur atom, are 
most widely used modified oligonucleotides because of their nuclease stability and their ease of 
synthesis (Fig. 7b). Another example of modifications on the phosphodiester linkage is the 
replacement of the oxygen at the 3’ position on the ribose by an amine group for the formation 
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Figure  7 : Selected modifications on phosphate group by varying the substituents. a) Metylphosphonate 




1.4 REPLACING THE SUGAR-PHOSHATE BACKBONE WITH ACYCLIC SCAFFOLDS 
 
Natural DNA has a D-(deoxy)-ribose phosphodiester backbone. The oligonucleotide modifications 
by varying the substituents on the sugar moiety or phosphodiester linkage have been mentioned 
in Chapter 1.4. The other approach for the modification on the backbone is altering the 
backbone topology through acyclic scaffolds in order to create novel informational oligomers 
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 Figure 8 : Chemical structures of nucleic acid analogs synthesized from acyclic scaffolds. a) 
Deoxyribonucleic acid DNA; b) Peptide nucleic acid PNA; c) Glycol nucleic acid GNA;[54] d) Acyclic 
threoninol nucleic acid aTNA;[55] e) Serinol nucleic acid SNA.[56] Numbers were assigned in order to show 
six bonds in the backbone for one repeat of DNA, PNA, aTNA and SNA; five bonds in the backbone for 
GNA. 
 
The sugar-phosphate backbone can be completely replaced with a non-natural acyclic linker for 
example a peptide linker while keeping the nucleobases in the case of peptide nucleic acids 
(PNAs).[57] PNAs are artificial nucleic acids with an acyclic and uncharged backbone. The sugar-
phosphate backbone was replaced by a N-(2-aminoethyl) glycine unit (Fig. 8b). The extremely 
high stabilities of PNA/PNA, PNA/DNA and PNA/RNA duplexes are due to the absence of 
electrostatic repulsion between the two strands because PNA has a neutral backbone.  
Apart from PNA, the backbone of oligonucleotides can be altered by replacing the ribose unit 
with a non-natural acyclic linker but keeping the phosphate group (Fig. 8c,d,e).[58–61] The 
chemical structure of completely artificial oligonucleotides, glycol nucleic acids (GNA), acyclic 
threoninol nucleic acids (aTNA) and serinol nucleic acid (SNA) are shown in Figure 8. Acyclic 
scaffolds are alkyl-based diol linkers. Various acyclic scaffolds have been used so far which can 
be termed as C2-, C3- or Cn- scaffolds due to the number of carbon atoms between two hydroxyl 
groups (Fig. 9).[62–66] Amongst acyclic scaffolds, glycerol, serinol and threoninol as C3-scaffold  are 
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most frequently used ones because they possess three carbon atoms  between two hydroxyl 
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Figure 9: a) The native nucleoside is given for a better comparison. b) Acyclic diol linkers used in 
oligonucleotide backbone modifications. Glycol has two carbon atoms between its two hydroxyl groups 
(C2-scaffold), whereas glycerol, serinol and threoninol have three carbon atoms similar to ribose of a 
native nucleoside (C3-scaffold). 
 
An acyclic glycol linker is used in order to synthesize GNA.[54,65] Nucleobases are tethered on the 
glycol linker and the two hydroxyl groups are converted into a phosphoramidite monomer which 
is compatible for utilization in an automated DNA synthesis. Likewise, aTNA is synthesized by 
using acyclic D-threoninol and SNA by using L-serinol as linear backbone.[56,67,68] Those 
oligonucleotide analogs have different solubility properties due to their individual backbone 
topology. They can recognize base-pairs with their complementary strands and have stacking 
abilities to form the double helical structure and some are more stable than natural DNA.[55] 
Although the glycol linker is more flexible than D-ribose, the GNA homoduplex found to be more 
stable than a DNA and RNA duplex.[55] Similarly homoduplexes of aTNA and SNA are more stable 
than DNA and RNA duplexes. The stabilities of homoduplexes are in the order of aTNA > PNA ≈ 
GNA ≥ SNA > RNA > DNA.[55] 
The presence of two hydroxyl groups in acyclic scaffolds makes it possible for their conversion 
into the phosphoramidite monomer, thus they can be easily coupled to each other or to natural 
nucleotides using a DNA synthesizer. After any functional molecule or nucleobase is attached on 
the acyclic linker, this scaffold can be introduced at any position in the oligonucleotide sequence 
through the corresponding phosphoramidite monomer. By using more than one acyclic 
modification in the same strand, the introduction of different kinds of functional molecules in 
the sequence is also possible. The utilization of acyclic scaffolds lies not only in the preparation 
of completely modified backbones but also in selective modification at desired position. Figure 
10 shows the backbone modifications as a result of incorporation of acyclic C2-, C3- or 
Cn- scaffolds in order to create a ribose-free site on the backbone.  The ribose-free site can carry 
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Figure 10: Backbone modified oligonucleotides with an acyclic scaffold. B: Nucleobase; R: Functional 
molecule.[61] 
 
There are some advantages of utilizing acyclic scaffolds in comparison to utilizing nucleoside 
scaffolds in order to incorporate functional molecules into oligonucleotides. The corresponding 
phosphoramidite of acyclic scaffolds are easily accessible compared to nucleoside scaffolds. In 
some cases the ribose ring of nucleoside scaffolds is not suitable for attaching some functional 
molecules that would sterically hinder the formation of the desired modification and destabilize 
the duplex. Particularly in these cases, acyclic scaffolds are an efficient choice when there are 
synthetic obstacles to attach functional molecules on natural nucleoside.  
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1.5  POST-SYNTHETIC FUNCTIONALIZATION OF DNA 
Modifications can be incorporated into oligonucleotides by DNA synthesis mainly by two 
approaches; direct incorporation and post-synthetic incorporation. With the direct approach the 
functional molecule is attached to the desired position of the nucleotide scaffold and then 
incorporated into DNA directly through the synthetic cycle as already described. Sometimes 
there are synthetic difficulties to prepare the corresponding phosphoramidite monomer of the 
unnatural molecule which is desired to be introduced into DNA. In this case the post-synthetic 
method is usually used. Furthermore, in some cases the incorporation of some functional 
molecules is incompatible with the oxidation step in DNA synthesis. In a post-synthetic 
approach, firstly, a nucleophilic reactive group is incorporated into oligonucleotide through the 
direct modification and then this reactive group is further functionalized with the desired 
molecule post-synthetically. The conventional reactive groups introduced before the post-
synthetic approach are amines and thiol groups. Other approaches that have most widely used 
for post-synthetic functionalizations are Diels-Alder reaction[69], click chemistry[70] and Staudinger 
ligation[38].  
The acyclic threoninol linker (Fig. 9, Chapter 1.4) is an efficient choice in order to incorporate 
amino or thiol functional groups into oligonucleotides. The presence of an amino or thiol group 
on the oligonucleotide enables the post-synthetic modifications. Threoninol whose amine is 
protected with an appropriate protecting group such as Fmoc or Alloc, can be introduced into 
oligonucleotides through the corresponding phosphoramidite monomer. After selective 
deprotection of the protecting group, a functional group with a carboxyl group or aldehyde 
group can be attached on the amine site of the oligonucleotide.[59] Likewise, a functional thiol 
group can be introduced into oligonucleotides as well, through the substitution of the amine 
group of threoninol with a thiol group.[71] Threoninol, carrying the protected thiol group, can be 
introduced into oligonucleotides through the phosphoramidite monomer. The formation of the 








2 POST-SYNTHETIC FUNCTIONALIZATION OF DNA 
THROUGH DYNAMIC COMBINATORIAL CHEMISTRY 
 
Two informational processes are fundamental to biological evolution. Firstly, the replication of 
the genetic information and secondly, transferring the information into functional molecules. 
These processes use DNA- or RNA-templates as source of information to encode its information 
into a new biopolymer. The desire to apply a similar process as Nature, chemists used DNA with 
templating property as an informational macromolecule for chemical synthesis of nonnatural 
nucleic acids in a process known as polymerase chain reaction (PCR). In Nature and in the PCR 
process, template-directed selection of nucleobase-carrying monomers and amplification for the 
generation of new oligonucleotides require the use of an enzyme. An alternative approach to 
translating the information into a new oligonucleotide analog relies on non-enzymatic template-
directed polymerization. Recently, dynamic combinatorial chemistry (DCC) has been used in non-
enzymatic template-directed reactions for the reversible assembling of new adaptive 
oligonucleotide analogs.[72] Furthermore, DCC enables the formation of informational oligomers 
with backbones other than phosphodiester backbone. 
In this chapter firstly, the principles of DCC concept will be outlined and followed by a brief 
discussion on previous scientific studies related to template-directed synthesis of oligonucleotides 
and their analogs. The combination of template-directed reactions with dynamic combinatorial 
chemistry (DCC) for reversible functionalization of oligonucleotides is discussed. Finally, the 










2.1 PRINCIPLES OF DYNAMIC COMBINATORIAL CHEMISTRY 
Combinatorial chemistry (CC) is a useful tool particularly for drug discovery as well as in the 
development of new catalysts.[73,74] In contrast to conventional synthesis where starting 
materials A and B react to obtain one product AB, in combinatorial synthesis different variants 
of A (for example ten variants of A1-A10) react with different variants of B (B1-B10). Each 
substance reacts with all other reactants such that in a single synthesis step it is possible to 
prepare a large number of products. For example, ten reagents of A react with ten reagents of B 
to generate a library with hundreds of variants of product AB in a single combinatorial library 
(CL).[75] Whilst CC is a rapid synthesis method, much time and effort is necessary for the 
purification and analysis of individual products in the library. Each product in the library needs to 
be synthesized independently in order to identify and isolate a selected product. Although high-
throughput screening techniques can accelerate these processes, still obstacles remain in 
combinatorial synthesis.[76]  
Dynamic combinatorial chemistry (DCC) is a subset of CC that aims to simplify the screeining 
process by generating self-screening libraries. In contrast to CC, DCC uses reversible reactions 
between building blocks carrying the functional groups for the generation of the library (or 
dynamic combinatorial library, DCL).[77–79] Through the reversible reaction, there is a continuous 
exchange of building blocks and interconversion of library members. The composition of the 
library is determined by thermodynamic stability of each member. If a template molecule is 
added into the library that will bind to a specific member through noncovalent interactions and 
remove it from the pool. The ability of the template to select the specific product will greatly 
simplify the screening process. Furthermore, during the selection process, the product 
distribution of the library would undergo a change in order to adapt itself. The schematic 
representation of the concept behind DCC is shown in Figure 11.[77,80] The design of DCC 
represents three basic requirements: (i) The preparation of the initial building blocks, (ii) 









Figure 11: The schematic representation of dynamic combinatorial chemistry (DCC). a) Initial building 
blocks carrying the functional groups; b) Dynamic combinatorial library (DCL) containing the all possible 
products formed by reversible reaction; c) The selection of the best-bound product through the 
template.(redrawn from [80]) 
 
2.1.1 THE PREPARATION OF THE INITIAL BUILDING BLOCKS 
 
Design of building blocks needs to fulfill some important features. Firstly, they must carry 
appropriate functional groups such as an amine, thiol or aldehyde for a reversible exchange. The 
rest of the molecule should not carry other functional groups that will interfere with the chosen 
exchange reaction. Secondly, they should possess functionalities to aid molecular recognition 
with the template. The geometry of the building blocks must fit in potential target sites.  
 
2.1.2 GENERATION OF DYNAMIC COMBINATORIAL LIBRARY (DCL) 
 
The DCC process is based on a reversible exchange reaction. Exchange reactions used in DCL 
could include covalent reactions, noncovalent interactions and metal-ligand coordination.  
Reversible covalent reactions, although slower, form more stable products and are easier to 
analyze and isolate. An applied reversible reaction has to be compatible with the experimental 
conditions, such as pH, solvent and/or temperature at a defined time of the experiment. Various 
types of reversible reactions have been used so far for the covalent binding of initial building 
blocks in aqueous media including imine, thioester, acetal, disulphide, acylhydrazone 
formation.[77,81] Initial building blocks must be prepared with appropriate functional groups (such 
as aldehydes, amines, thiols) which allows the reversible exchange with one another due to the 
chosen reversible reaction. In a reversible DCC process there is a continuous formation and 
breaking of covalent bonds between the initial building blocks until the equilibrium is 
reached.[77,78,82,83] Once the equilibrium is reached all possible products of the system generate a 
dynamic combinatorial library (DCL).  
Due to its reversibility, the dynamic library has an adaptive behavior against any change in the 





reorganization between the building blocks of the library in order to minimize the total free 
energy of the system. Thus, the proportions of the library members can be controlled by 
adjusting the reaction conditions and the equilibrium can be shifted towards the desired 
product. This flexible and adaptive nature of the dynamic library is the advantage over its static 
library.  
The external changes can include altering the pH, temperature, electric field or adding/removing 
reactants, but the most exploited one is the addition of a template to encourage the formation 
of a particular product. The addition of a template into the reaction mixture, or so-called 
template-directed reactions, with the intention of selecting one specific product relies on 
molecular recognitions between the template and initial building blocks. Molecular recognition 
results from reversible non-covalent forces such as hydrogen bonding, electrostatic interactions, 
metal coordination, donor-acceptor interactions, and π-π stacking interactions. Behind 
molecular recognition there is also a dynamic character, reversible assembly/disassembly 
process. It is equilibrium-controlled and generates the thermodynamically most stable 
assembly.[84] Thus DCC is a combination of non-covalent self-assembly processes and reversible 
covalent formation. DNA has an important place as a template, due to the self-assembly and 
recognition potential through hydrogen bonding. 
 
2.1.3 SELECTION AND AMPLIFICATION OF THE BEST-BINDER 
 
In a dynamic library at equilibrium, the addition of a template which binds selectively to one of 
the products (through molecular recognition) will result in a shift of the equilibrium towards this 
product. The concentration of this best bound product will be increased at the expense of the 
others. The desired molecule will be stabilized once trapped by the template, whereas the rest 
of the unbound products continue to be exchanged. That is a self-screening process and makes 
the isolation and identification of the desired molecule easier for DCC. One advantage of DCC 
over CC is the combination of the library generation and screening process in a single step. 
Furthermore, in order to obtain the desired product in high efficiency, the parameters of DCC 
can be changed such as the introduction of the right template, which is fitting to the structural 
properties of the desired product. Finally, all the possible products in the library must be 







2.2 DCC THROUGH REVERSIBLE IMINE FORMATION 
Among the various reversible covalent reactions imine formation through condensation of 
aldehydes with amines has special interest because of its role in biological processes (Fig. 12). 
Imine bonds are ideal for DCLs because their formation are fast and reversible under 











1ry amine aldehyde imine amine  
Figure 12: Reversible formation of imines from primary amines and aldehydes followed by the reduction 
of imines to amines by addition of sodium cyanoborhydride. 
 
Imine bond formation involves the loss of H2O so the addition of water to the imine product 
leads to hydrolysis and drives the equilibrium to the other direction leading to the formation of 
starting materials.[84] Most imine formation reactions are carried out in organic solvents in order 
to shift the reversible imine formation towards the condensation product. During imine 
formation water removal is necessary with diaryl or arylalkyl ketones, but aldehydes can usually 
be condensed with amines without removing water from reaction mixture.[83] Although the 
general features of imine formation are well understood, imine formation in water is limited.[85] 
Imine formation in the field of dynamic combinatorial chemistry is usually performed in aqueous 
organic mixtures[86] or aqueous solutions because reversibility is necessary for the generation of 
libraries of dynamic compounds.[87,88] Furthermore, the instability of imines in aqueous solution 
causes analytical and isolation problems within the DCC concept. The solution for this obstacle is 
the reduction of imine to amine by addition of sodium cyanoborhydride (Fig. 12).[89] Reductive 




2.3 APPLICATION OF DCC FOR FUNCTIONALIZATION OF OLIGONUCLEOTIDE 
ANALOGS 
 
Dynamic combinatorial chemistry is mostly used as a tool for drug discovery processes in the 
search of new bioactive molecules with an affinity to biomacromolecules.[79,81,83,91–94] Recently, 
the DCC approach has been extended to the generation of new adaptive oligonucleotide 
analogs.[95] Oligomers of this type have been prepared by reversible coupling of monomeric units 
in the presence of a DNA (RNA or PNA as well) template. The selection of monomeric units 
(monomeric nucleotides or nucleobases) is directed by base-pairing between the template and 
the monomers. The transfer of the information coded in the nucleobase sequence of the 
template into the new assembled oligonucleotide analog represents a simple model to DNA 
replication. In contrast to Nature and enzymatic DNA polymerization in the PCR process, the 
templated replication using DCC is reversible, therefore, allows for error correction.  
Template-directed synthesis of oligonucleotide analogs can be designed in two ways; backbone 
ligation and base-filling approaches.[21,96] (i) Backbone ligation; is the construction of the 
backbone of the oligomer from combination of either monomeric nucleotides or of short 
oligonucleotides (Fig. 13a). The coupling of suitably functionalized monomeric nucleotides can 
generate a new backbone other than native DNA backbone. (ii) Base-filling; is the addition of 
monomeric nucleobases to a pre-formed abasic backbone (Fig. 13b). The attachment of the 












Figure 13: Two strategies for templated synthesis of oligonucleotides illustrated in the example of DNA 
backbone. a) Templated oligonucleotide synthesis by backbone ligation; b) Templated oligonucleotide 
synthesis by base-filling.(redrawn from [97]) 
 
If the backbone ligation or base-filling processes are performed by using a reversible reaction 
under thermodynamic control, the new synthetic informational oligomer would be responsive to 
a selection pressure. The attachment of nucleobases can be continuously and reversibly 
exchanged as a result of the addition of a new template strand with different sequence.  
 
 
2.3.1 BACKBONE LIGATION 
 
Early attempts for template-directed oligonucleotide synthesis focused on backbone ligation 
through a coupling reaction between two monomeric nucleotides or short oligonucleotides by 
joining backbone functional groups where DNA, RNA or PNA was used as template.[98–105] The 
first application of backbone ligation used an irreversible reaction to form phosphodiester 
bond.[106] Short oligonucleotides were bound to their complementary sites along a template 
through hydrogen-bonding. The adjacent monomers on the template, one of them was carrying 
hydroxyl group at 3'-end and the other one was carrying a phosphate group at 5'-end, are 
coupled forming a phosphodiester bond in presence of a suitable activator (Fig 14a). The 
macromolecular template directs the reaction by bringing the reactive species in close proximity 
and hence, increasing the effective molarity of the reactive groups.[107] In addition to the 
phosphodiester backbone formation other reactions such as amine acylation, amide formation, 
phosphothioester and phosphoseleno formation could be performed to generate oligomers of 
DNA analogs by using backbone modified nucleotides with the required appropriate reactive 






































































Figure 14: a) Representative DNA-templated phosphodiester formation through backbone ligation of short 
oligonucleotides. Two nucleotides were coupled to form the native phosphodiester backbone.[106] LG: 
Leaving group. b) Representative DNA-templated imine formation through backbone ligation of short 
oligonucleotides.[108] 
 
In order to synthesize oligonucleotide analogs on a template, a reversible reaction could be 
employed as well. The introduction of a reversible step enhances thermodynamic control in the 
template-directed synthesis.[108] As shown in Figure 14b, incubation of 5'-amino and 3'-aldehyde 
functionalized DNA oligonucleotides with a complementary DNA template result in formation of 





functional groups in close proximity and formation of an imine-linked new oligonucleotide can 
be observed.[111]  
The above given examples show the formation of a single imine bond without generating a DCL 
by reversible coupling of two short oligonucleotides on the template. This concept can be 
extended to the sequence-specific polymerization of nucleic acids in presence of a DCL.[105] Non-
enzymatic polymerization typically uses one DNA (RNA or PNA) template and a pool of 
nucleotide monomers (G, C, T, A) for coupling along the template. Nucleotide monomers are 
selected from the pool by template strand. One of the nucleobase monomers from the pool, the 
one complementary to the template strand´s nucleobase should be selected. In this manner, 
information on the template strand could be transferred from template to the new synthesized 
strand. The new synthesized strand could carry an imine bond function (or amine by reduction of 
the imine bond) on its backbone if the nucleotides bear an amino function at one end and an 
aldehyde at the other end (Fig. 15). In this manner, monomers containing a nonnatural 
backbone could generate DNA or RNA mimicking oligomers containing ribose unit on the 


















































DNA Template  
Figure 15: Schematic representation of a DNA-templated polymerization through backbone ligation used 
in the work of LYNN and co-workers.[101] 
 
2.3.2 BASE-FILLING REACTIONS 
 
Sequence-selective base-filling approach is an alternative route to non-enzymatic nucleic acid 
synthesis and considers the addition of individual monomeric nucleobases to a pre-formed 
abasic backbone. Initial attempts used an abasic ribose-phosphate backbone for the attachment 
of nucleobases on the abasic site through the formation of a N-glycosidic bond. However, the 
formation of a N-glycosidic bond between a ribose unit and a nucleobase in water is a 









































Figure 16: Schematic representation of a base-filling process on an abasic site of DNA backbone by N-
glycosidic bond formation. 
 
Since the N-glycosidic bond formation without catalyst is unfavorable,  LIU and co-workers have 
used, a nucleic acid variant, PNA backbone for base-filling reactions instead of using a DNA 
backbone.[97] PNA is a good candidate for base-filling reactions because its abasic site is a 
versatile secondary amine. This amine site on the backbone would be filled more favorable than 
N-glycosidic bond formation through amine acylation or reductive amination by modifying the 
nucleobase monomers with appropriate functional groups (Fig. 17, `blank site´ is dashed boxed). 
Therefore, the individual nucleobase monomers (A, G, C, T) are prepared with carboxylic acid or 
aldehyde groups that can react with amine group on the backbone. The PNA with abasic site is 
pre-annealed to its complementary PNA strand. In the presence of all nucleobase monomers in 
the reaction mixture, the proper monomer is selectively bound on the pre-annealed PNA duplex. 
The tethered nucleobase is selected among all other nucleobases through the recognition of the 
complementary nucleobase on the template opposite to the blank site. In Figure 17 the selection 
of a guanine nucleobase through templating of PNA carrying cytosine in its sequence is shown. 
Base-filling of PNA by amine acylation generates native PNA and by reductive amination 
generates artificial PNA with a new backbone so-called deoxyPNA. For base-filling, both a 
reversible reaction through reductive amination and an irreversible acylation reaction were 
reported and both of them show sequence selectivity. However, better yields and selectivities 
are obtained by reductive amination. Dynamic iminium formation allows for error correction by 































































































Figure  17: Base-filling chemistry on a PNA backbone used in the work of LUI and co-workers.[114] The 
selective incorporation of a guanine nucleobase is shown. a) The base-filling reaction for incorporation of 
nucleobase monomers through reductive amination to generate native PNA. b) The base-filling reaction 
for incorporation of nucleobase monomers through amine acylation to generate deoxyPNA. 
 
A similar work for base-filling reactions by using a PNA backbone was performed by BRADLEY and 
co-workers.[115] Reversible imine exchange reaction was used in order to incorporate aldehyde 
modified nucleobase monomers on a single abasic site (a secondary amine) of the PNA. In this 
concept, the PNA with abasic blank site was hybridized to a DNA template. The correct 
nucleobase was selectively incorporated to fill the abasic site which could be then identified by 
MALDI mass spectrometry. Thus, the blank site on PNA was used to read out the unknown 
nucleotide of the DNA template. The nucleobase which was selectively bound on the blank site 
was used to identify the unknown site on the DNA strand.  
Recently GHADIRI and co-workers used a regular peptide backbone for the reversible attachment 
of nucleobases on that backbone.[72] This work shows the application of dynamic combinatorial 
chemistry for synthesizing an artificial oligomer with a peptide backbone carrying nucleobases 
on its amino acid side chains. This regular peptide consists of a cysteine moiety as every second 
amino acid in its sequence. Thioester exchange reaction is used for the reversible attachment of 
modified nucleobases onto the peptide backbone (Fig. 18). By addition of nucleobases with 
thioester-linkage at cysteines of the backbone, a new PNA-like oligomer carrying nucleobase 
recognition units is created and denoted as thioester PNA (tPNA). The selection process of the 
best-binding one among all four nucleobases is directed by a DNA template. The nucleobase 
sequence of the template decides the incorporation of the right nucleobase through base-





including thymine in its sequence is shown. tPNA oligomers are the first example of reversible 
artificial informational oligomers. Sequence of tPNA would adapt itself to any change of 
nucleobase sequence in the template strand. The reversible nature of a new adaptive and 





































                                               











T= thymine  
Figure 18: The schematic representation of transesterification exchange mechanism used in the work of 
GHADIRI and co-workers showed the formation of thioester peptide nucleic acids (tPNA) by reversibly 





2.4 THE APPROACH OF THIS STUDY 
Several classes of nucleic acid analogs varying in backbone structure have been reported.[116] The 
idea for modification of the native nucleic acid by replacing the ribose unit of the backbone with 
an acyclic linker was inspired from ASANUMA and co-workers.[61] This work includes the 
incorporation of a D-threoninol-based acylic linker into the oligonucleotide strand in order to 
generate a ribose free (acyclic) site in the backbone which lacks the nucleobase. The use of D-
threoninol within the strand not only introduces an abasic ribose free site but also results in the 
introduction of an amine group on the backbone (Fig. 19). The presence of the reactive amine 
group enables further functionalization of the oligonucleotide by filling this abasic site with 
appropriate functional molecules. Various functional molecules of interest can be tethered 
irreversibly with a carboxyl group or reversibly with an aldehyde group to the amine group post-
synthetically such as functional molecules fluorophores, metal ligands or the natural nucleobase 
monomers. The incorporation of nucleobases at the abasic site would be a post-functionalization 
approach for the non-enzymatic synthesis of informational oligomers. Dynamic Combinatorial 
Chemistry (DCC) can be applied for the post-synthetic functionalization of the backbone 
modified oligonucleotides with an acyclic and abasic site. 
The idea to attach nucleobase monomers reversibly to the backbone of a linear oligomer in 
order to obtain new informational oligomers was inspired from GHADIRI.  The use of peptide 
nucleic acid (PNA) carrying abasic sites on its linear backbone or regular linear peptide backbone 
are good candidates to attach nucleobase monomers on the abasic sites through dynamic 
chemistry approach. However, none of the abasic DNA backbones have been used for 
nucleobase filling approach due to the difficulties faced during the attachment of nucleobases 
directly on the ribose unit. The presence of ribose free site carrying a reactive amine group on 
the backbone of oligonucleotides synthesized while working on this thesis makes DNA also a 
good candidate for the reversible attachment of nucleobase monomers on the backbone.  
The aim of this work is the utilization of modified abasic and acyclic oligonucleotides for the non-





Figure 19: Schematic representation of the model system used in this work in order to functionalize the 
backbone modified oligonucleotide through dynamic chemistry approach. 
 
If all four nucleobases are prepared with an aldehyde group, the imine formation reaction can 
be used for filling the blank abasic position through reversible reaction of aldehyde nucleobases 
with a primary amine on the backbone. The attachment of nucleobase monomers on the 
backbone sites could be only achieved in the presence of complementary strand as a template 
to provide the required recognition and effective molarity for the reaction. The addition of a 
DNA template into the reaction may selectively choose the best binding nucleobase monomer to 
fill the blank position and direct the formation of thermodynamically most stable product 
through sequence specific recognition. This work represents the non-enzymatic encoding of a 











3 DESIGNING DYNAMIC COMBINATORIAL MODEL SYSTEM 
 
In this chapter the design of a model dynamic system for DNA-templated base-filling reactions on 
a DNA backbone is shown. The investigations for the selective incorporation of nucleobase 
monomers on the abasic site of a pre-formed acyclic DNA backbone is discussed.  
Firstly, the synthetic routes for the building blocks, which are backbone modified DNA and 
aldehyde modified nucleobases, is given. Secondly, library (DCL) generation conditions through 
imine exchange reaction and simultaneous selection of the desired product by introduction of the 
DNA-template are provided. The questions related to the selectivity that could be obtained by 
introduction of the right template are answered. Finally analysis of the DCL through HPLC and 













3.1 SYNTHESIS OF INITIAL BUILDING BLOCKS OF A DYNAMIC LIBRARY 
The building blocks for the DCL are the modified oligonucleotide with an amine group on the 
backbone (Fig. 20a) and four nucleobases carrying an aldehyde group (Fig. 20b). The 
incorporation of D-threoninol-based acyclic scaffold results in the formation of a functional 
amine group on the backbone of the oligonucleotide which required the modifications of 
nucleobases with aldehyde groups in order to fill the abasic site through a reversible imine 
exchange reaction. Apart from canonical nucleobases, 1,10-phenantroline ligand was also 














































                                              
b) 
                                                                                                                   
c)
ON1
      
9 
                             
17 
                       
12 











Figure 20: The initial building blocks of the dynamic combinatorial model system applied in this work. 
Building blocks should be prepared with appropriate amine and aldehyde functionalities due to the imine 
exchange reaction used to generate DCL. a) Modified oligonucleotide with an amino group, ON1; b) A set 
of aldehyde modified nucleobases, GCHO, CCHO, ACHO and TCHO. c) Aldehyde substituted phenantroline, 
P2CHO. 
 
3.1.1  SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES BASED ON D-THREONINOL 
3.1.1.1 USE OF THE THREONINOL AS ACYCLIC SCAFFOLD 
 
Threoninol (2-amino-1,3-butanediol) is a very efficient and most frequently used C3-scaffold for 
the introduction of functional molecules into oligonucleotides.[61] The same number of carbon 
atoms between two alcohol groups on threoninol makes its structure similar to natural DNA 
backbone (carbon atoms between two phosphodiester) (Fig. 21). Unlike other C3-scaffolds as 




group on the threoninol. Threoninol which can be synthesized from threonine is commercially 


















Figure 21: Synthesis of D-threoninol through reduction of D-threonine methyl ester. 
 
In this work, the use of D-threoninol instead of L-threoninol for the backbone modification of 
oligonucleotides was important because the incorporation of D-threoninol was known to 
stabilize the DNA duplex much more than the use of L-threoninol.[117–121] ASANUMA and co-
workers investigated the introduction of azobenzene moiety into DNA through the use of both 
D-threoninol and L-threoninol scaffolds for the photoregulation of duplex formation.[120] When 
azobenzene was attached to D-threoninol, the photoregulation function was higher than L-
threoninol as a result of its winding property. Since both the natural DNA and D-threoninol 
prefer clockwise winding, the incorporation of azobenzene through D-threoninol was much more 
stable than its enantiomer L-threoninol.[61] 
The D-threoninol scaffold can be incorporated into oligonucleotides via its corresponding 
phosphoramidite monomer which is suitable for automated DNA synthesis. In the conversion 
route of threoninol into the phosphoramidite monomer, the first step usually includes the 
attachment of a base-surrogate (a functional molecule or a nucleobase) mostly carrying a 
carboxyl group to the primary amine of threoninol through amide bond. After attachment of 
base-surrogates, it is easily converted to phosphoramidite monomers by using the two hydroxyl 
groups (Fig. 22). Thus, a functional molecule on threoninol scaffold can be introduced at any 



















The primary amine of threoninol might or might not carry base-surrogates. The incorporation of 
a threoninol linker (with free amine group, no base-surrogate) into oligonucleotides would 
change the backbone structure and lower the duplex stability because of the distortion in the 
backbone.[122] However attachment of base-surrogates on amine group can compensate for 
instability particularly if those base-surrogates are aromatic planar molecules. Incorporation of 
base-surrogates into oligonucleotides offers a variety of duplex designs (Fig. 23). Base-surrogates 
on the threoninol linker can pair with itself or with a natural/modified nucleobase on the 
complementary strand (Fig. 23a, b). A wedge-type insertion means that the base-surrogate 
attached on the amine group of threoninol has nothing to pair opposite of its complementary 
strand (Fig. 23c).[61] 
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Figure 23: The possible sequence designs for the incorporation of acyclic scaffolds into the 
oligonucleotides. a) Two base surrogates can be pairing in a duplex; b) One base-surrogate can pair In a 
mismatch pattern with a natural or modified nucleobase; c) Wedge-type insertion of base-surrogate that 
has nothing to pair opposite of its complementary abasic strand.(adapted from [71]) 
 
Wedge-type insertion of threoninol scaffolds carrying moieties such as psoralen, acridine, 
azobenzene, dyes or natural bases into natural DNA can fairly stabilize the duplex even when 
more than one threoninol is inserted. The planar structure of these molecules acts as an 
intercalator and stabilizes the duplex by stacking interactions. The melting temperature (Tm) of 
the duplex containing Wedge-type inserted dyes was found to be higher than the native duplex. 
In contrast incorporation of the same dyes opposite of a natural nucleotide to form an dye-
nucleobase mismatch destabilizes the duplex because of steric hindrance.[61] However, not all 
intercalated planar molecules stabilize the duplex. Molecular size of the tethered functional 




Watson-Crick base-pair is around 11 Å, intercalated functional molecules of similar length fit the 
internal space between adjacent base-pairs and stabilize the duplex. The functional molecules 
with length higher than 11 Å lower the duplex stability as they are too long to intercalate due to 
the steric hindrance. Destabilization also occurs when a smaller sized intercalator is tethered to 
threoninol because of insufficient stacking interactions.[61] 
3.1.1.2 SYNTHESIS OF THE D-THREONINOL-BASED PHOSPHORAMIDITE MONOMER 
 
For the work employed in this thesis no functional molecule but a reactive amino group on the 
oligonucleotide backbone was necessary (Fig. 20a, Chapter 3.1). Therefore, from the 
commercially purchased D-threoninol (1), a phosphoramidite monomer (4) was synthesized in 
three facile steps (Fig. 24). In the initial step the primary amine of D-threoninol (1) was protected 
with a suitable, base labile 9-fluorenyl-methylcarbonyl (Fmoc) group in 90% yield in order to 
prevent the side reactions. The Fmoc group can be easily removed in the subsequent steps after 
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Figure 24: Synthetic route for phosphoramidite monomer (4) from commercially available D-threoninol 
(1). 
 
After protection of the amino group, the primary hydroxyl group of the D-threoninol (1) was 
protected with a DMT group and the secondary hydroxyl group was converted into the 
phosphoramidite. Since DMT selectively reacts with the primary alcohol, the presence of an 
additional methyl group on the threoninol brings selectivity for the protection of the primary 




group in the presence of triethylamine in dry pyridine under argon. The presence of 
4-(dimethylamino)-pyridine (DMAP) also catalyzes the selective tritylation of the primary alcohol 
to give the derivative 3 in 82% yield. During the purification of derivative 3 by flash column 
chromatography, small amounts of triethylamine were added into the eluent. This was 
necessary due to the fact that silica gel was known to be acidic. Prior to the reaction, the co-
evaporation of the Fmoc-D-threoninol (2) with dry prydine resulted in better yields of derivative 
3. 
The third step is the phosphitylation of the secondary hydroxyl group. It was achieved by 
treating derivative 3 with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite and 
N,N-diisopropylethylamine (DIPEA) in dry dichloromethane under argon for three hours. 
Purification by flash column chromatography and precipitation into cold hexane afforded 
derivative 4 in 43% yield. The phosphoramidite monomer was characterized by 31P NMR 
spectroscopy which shows two diastereomers with two peaks at 147.92 and 148.18 ppm. The 
(PIII) of the phosphoramidite is air and moisture sensitive. For this reason it had to be prepared 
under strictly anhydrous conditions using argon. 
3.1.1.3 INCORPORATION INTO OLIGONUCLEOTIDES 
 
The phosphoramidite monomer 4 was incorporated into oligonucleotides via automated solid 
phase DNA synthesis. The synthetis cycle for the elongation of the oligonucleotide chain 
performed in the DNA synthesizer is shown in Figure 25.  
The oligonucleotide chain was synthesized on a controlled pore glass (CPG) from 3'- to 5'-end. 
For every step, anhydrous acetonitrile was used as the solvent. The cycle started with the 
detritylation of the starting nucleoside by treatment with 3% dichloroacetic acid in toluene on 
the solid support. Following the detritylation, the support-bound nucleoside was coupled with 
the next nucleoside phosphoramidite monomer which was activated with 5-
benzylmercaptotetrazole by protonating the diisopropylamino group. The attack of the 5'-OH 
group of the support-bound nucleoside to the phosphorus atom of activated phosphoramidite 
created a support-bound phosphite-triester. The unreacted 5'-OH groups on the resin-bound 
nucleoside were capped with acetyl groups to avoid them to participate to next reaction steps. 
The unstable phosphite-triester (PIII) intermediate formed in the coupling step was converted to 
a stable (PV) species prior to the next detritylation step. The oxidation of (PIII) was achieved by 
0.02 M Iodine in THF/pyridine. The resultant phosphotriester gave a DNA backbone protected 
with a 2-cyanoethyl group. The 2-cyanoethyl group prevents undesirable reactions at 


























































































Figure 25: Oligonucleotide synthesis cycle on a solid support by using an automated DNA synthesizer.  
 
The last step was detritylation of the 5'-end group on the newly synthesized strand. After 
detritylation, a new synthetic cycle can start to introduce the next nucleoside until the desired 
sequence/length is obtained.  
After completion of the full length sequence, the synthesized strand was cleaved from the 
support while the last nucleotide of the sequence was still carrying the 5'-DMT group.  The 
cleavage from the CPG support was performed manually. This was done by ammonium 
hydroxide at 50 °C for overnight. Under these conditions the protecting groups on 
the heterocyclic bases, 2-cyanoethyl groups on the phosphate groups and Fmoc groups on the 
primary amine were all removed (Fig. 26). After the cleavage process, the obtained solution was 
filtered and the product was further purified by preparative RP-HPLC. The collected fractions 
were lyophilized. 
The 5'-DMT group on the synthesized oligonucleotides were manually removed. The 
detritylation of 5'-DMT group was done by a treatment with 80% acetic acid at room 
temperature for one hour. During the cleavage of the trityl moiety from the oligonucleotide 




Table 1 The sequences of the modified oligonucleotides synthesized in this work. 
 
a ‘X’ represents the abasic site with amino group. 
b ON1 was used in further studies in the dynamic base-filling reactions. 
passed through Sep-Pak® cartridges in order to avoid from the trityl cation. The analysis of the 










































































Figure 26: Phosphoramidite monomer was incorporated into oligonucleotide via automated synthesis on a 
solid support. DMT-ON synthesis was performed. The protection groups on nucleobases, on phosphate 
groups and Fmoc group were removed using ammonium hydroxide. 
 
The free amine functionality was built on the backbone of the synthesized oligonucleotides 
through the use of phosphoramidite monomer 4. The phosphoramidite monomer 4 was 
incorporated into non-self-complementary 13mer oligonucleotides. The sequences of the 
synthesized oligonucleotides are shown in Table 1. Singly modified oligonucleotides, carrying the 
acyclic site in the middle (ON1) and at the end (ON3) of the sequence were prepared. The 
incorporation was achieved at both places in the same sequence as well (ON2). In natural DNA 
backbone the distance between 5'- hydroxy groups of two adjacent nucleotides is length of 6-
bonds. Substitution of D-threoninol in the backbone fulfills the requirement of length of 6-bonds.  
 
ON Sequence (5'-3') a Mass (m/z) 
















3.1.1.4 MELTING TEMPERATURE STUDIES 
 
In order to investigate if threoninol sites in the oligonucleotide backbone disturb hybridization 
with their complementary DNA strands, the duplex melting temperatures (Tm) were measured 
for probes ON1-2, carrying one and two threoninol sites respectively. A series of melting 
temperature experiments were conducted for ON1, 5'-d(CGCTATXTATCGC) (X = threoninol site) 
with its four complementary strands 5'-d(GCGATAYATAGCG) (Y = dG; Y = dC; Y = dA; Y = dT) 
containing the guanine, cytosine, adenine and thymine residue opposite to the threoninol site. 
These results were compared with the corresponding natural DNA-DNA duplex 
5'-d(CGCTATXTATCGC) ∙ 5'-d(GCGATAYATAGCG) where X = dG, Y = dC; X = dC, Y = dG; X = dA, 
Y = dT; X = dT, Y = dA (Fig. 27).  
 
 
Figure 27: Comparison of melting curves for the duplex formation for ON1 with its complementary 
strands, 5'-d(CGCTATXTATCGC)-3'∙5'-d(GCGATAYATAGCG)-3' (X = threoninol, Y = dG; Y = dC; Y = dA; 
Y = dT) (up) and for  natural DNA∙DNA duplexes, 5'-d(CGCTATXTATCGC)-3'∙5'-d(GCGATAYATAGCG)-3' 
(X = dG,Y = dC; X = dC,Y = dG; X = dA,Y = dT; X = dT, Y = dA). (2,5 µM ds-DNA, 10 mM sodium phosphate 
buffer, pH 7, 100 mM NaCl). The absorbance values have been normalized to allow better comparison. 
 
As shown in Figure 27, the 1:1 mixture of ON1 with its four complementary strands exhibited a 
typical sigmoidal curve. In comparison to its natural duplex, the incorporated threoninol site in 
the central position lowered the melting temperature significantly (ΔTm ≈ - 17 °C) because of the 
distortion in the duplex (Table 2). However, it has been reported that the incorporation of 
functional molecules such as dyes with planar structures and stacking interactions straightens 




Table 2 Melting temperatures (Tm) of oligonucleotide ON1 and its native duplex. 
 




nucleobases on the threoninol site of ON1 for the approach of this thesis, would stabilize the 
duplex. 
 
Duplex Tm/°C a 
X = threoninol, Y=dG (X=dC, Y=dG) 35.5 (54.0) 
X = threoninol, Y=dC (X=dG, Y=dC) 34.1 (53.2) 
X = threoninol, Y=dA (X=dT, Y=dA) 34.5 (51.1) 
X = threoninol, Y=dT (X=dA, Y=dT) 33.7 (49.2) 
 
 
The melting temperatures were conducted for ON2, CGXTATXTATCGC (X = threoninol site), 
which had an extra second threoninol site at the end of the strand (Fig. 28). The same 
complementary strands were used as for ON1 with sequence GCGATAYATAGCG (Y = dG; Y = dC; 
Y = dA; Y = dT). As shown in Figure 28, the broader melting transitions were observed for ON2 
with two threoninol sites as compared to ON1 with one threoninol site indicating that the 
hybridization is less cooperative. In comparison to ON1, the presence of a second threoninol site 
in the same strand lowered the melting temperature (ΔTm ≈ - 10 °C). 
 
 
Figure 28: Melting curves for the duplex formation for ON2, 5'-d(CGXTATXTATCGC)-3'∙5'-
d(GCGATAYATAGCG)-3'. (Y = dG; Y = dC; Y = dA; Y = dT). (2,5 µM ds-DNA, 10 mM sodium phosphate buffer, 






3.1.2 SYNTHESIS OF ALDEHYDE-MODIFIED NUCLEOBASES 
 
Depending on the chosen imine exchange reaction, the four nucleobase-aldehydes were 
prepared (GCHO, CCHO, ACHO and TCHO; Chapter 3.1, Fig. 20). Literature known synthesis was 
applied; initially, nucleobases were alkylated with bromoacetaldehyde diethyl acetal at the N1- 
or N9-position of pyrimidine or purines, respectively.[123,124] Diethyl acetal nucleobases were then 
hydrolyzed to aldehydes in aqueous trifluoroacetic acid (TFA) through microwave radiation 
reactions.[125] Aldehydes of nucleobases were obtained as TFA salts of their hydrates.  
In the case of guanine, 2-amino-6-chloropurine (5) was used as starting material which has a 
higher solubility and allows a selective alkylation at the N9- over N7-position (Fig. 29). In the first 
step, 2-amino-6-chloropurine (5) was alkylated with bromoacetaldehyde diethyl acetal in the 
presence of cesium carbonate in N,N-dimethylformamide (DMF) at 110 °C for 24 hours. Under 
these conditions the alkylation was directed predominantly to the N9-position to afford the 
alkylated derivative 6 in 60% yield. Afterwards, substitution of the 6-chloro atom by oxygen 
atom was necessary in order to generate the keto group of the guanine derivative 7. This was 
achieved by alkaline hydrolysis of the derivative 6 in the presence of 
1,4-diazabicyclo[2.2.2]oktane (DABCO) and potassium carbonate under reflux for two hours. For 
deionization of the reaction mixture, the solution of products was passed through an ion-
exchange column using Dowex. After deionization, derivative 7 was obtained in 60% yield. The 
acidic hydrolysis of derivative 7 was performed in 1 M HCl by refluxing at 95 °C for one hour to 
give derivative 8 in 50% yield.  
In another accelerated route, the nucleophilic aromatic substitution of the chloride and acidic 
hydrolysis of derivative 6 was combined in a single step through the use of microwave radiation 
in aqueous TFA at 100 °C for 30 minutes.  GCHO (9) was obtained as hydrate trifluoroacetate as a 




















































Figure 29:  Synthetic route of aldehyde modified guanine nucleobase, GCHO. 
 
Alkylation of adenine (10) at N9 was performed using the same route as described for guanine 
(Fig. 30). Adenine was alkylated in the presence of bromoacetaldehyde diethyl acetal and 
potassium carbonate in DMF at 110 °C. After 24 hours acetal 11 was afforded in 60% yield. The 
hydrolysis of the derivative 11 in aqueous TFA in microwave at 110 °C for 30 minutes gave 
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Figure 30: Synthetic route of aldehyde modified adenine nucleobase, ACHO. 
 
Before the alkylation of cytosine, it was necessary to protect the exocyclic amine by an acyl (Ac) 
group (Fig. 31). Cytosine (13) was treated with acetic anhydride and acetic acid for 17 hours 
under reflux to afford the protected cytosine (14) in 88% yield. Following this, the derivative 14 
and bromoacetaldehyde diethyl acetal was heated up to 110 °C in DMF in the presence of 
cesium carbonate for 24 hours to give N1-alkylated cytosine (15) in 60% yield. After alkylation, 
the Ac protecting group was removed with methanolic ammonia to afford derivative 16. Acidic 
hydrolysis of the derivative 16 in aqeous TFA gave aldehyde modified cytosine CCHO (17) in 90% 
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Figure 31: Synthetic route of aldehyde modified cytosine nucleobase, CCHO. 
 
In a similar route, thymine (18) was alkylated at the N1-position with bromoacetaldehyde diethyl 
acetal to afford derivative 19 in 55% yield which was then hydrolyzed by refluxing in aqueous 
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Figure 32: Synthetic route of aldehyde modified thymine nucleobase, TCHO. 
 
3.1.3 SYNTHESIS OF ALDEHYDE-MODIFIED PHENANTROLINE 
 
1,10-Phenantroline-based ligands are important class of chelating agents with large π-surface 
(Fig. 33).[126] The planar nature of 1,10-phenantroline can interact with DNA as either 
intercalating or groove-binding species.[127] Furthermore, covalent incorporation of non-
nucleosidic, phenantroline-derived building blocks into DNA as a base surrogate without 
destabilizing the DNA duplex has been already reported.[128,129] The use of these base surrogates 
can effectively enhance the duplex stability of DNA with an abasic site. The stabilization results 



























Figure 33: Schematic representation of phenantroline-based ligands. a) 1,10-phenantroline; b) Derivatives 
of 1,10-phenantroline with extended aromatic surfaces. 
 
Considering these properties, the aldehyde substituted 1,10-phenantroline derivatives, 9-
methyl-1,10-phenantroline-2-carbaldehyde, P1CHO (25, Fig. 34) and 1,10-phenantroline-2-
carbaldehyde, P2CHO (29, Fig. 35) were synthesized in order to attach them to the amino group 
on the backbone of ON1. Apart from the incorporation of nucleobases on ON1, the dynamic 
chemistry approach could provide an aspect for its application as dynamic combinatorial catalyst 
formation particularly for enantioselective reactions by attaching catalytic species or metal 
ligands into the oligonucleotides.  
In the first place, the synthesis of 9-methyl-1,10-phenantroline-2-carbaldehyde (P1CHO) was 
initiated but afterwards, 1,10-phenantroline-2-carbaldehyde (P2CHO) was noticed to be 
synthesized in two-steps and in better yields. The only structural difference between P1CHO and 
P2CHO is that P1CHO has one methyl substituent on the ring at C9-position. P2CHO was used in 
further studies for its incorporation into DNA. 
For the synthesis of 9-methyl-1,10-phenantroline-2-carbaldehyde (P1CHO), commercially 
available 2,9-dimethyl-1,10-phenantroline (21) was chosen as starting material (Fig. 34). In order 
to enhance the reactivity of derivative 21, mono-N-oxide derivative 22 was synthesized in 
quantitative yield by selective oxidation of derivative 21 with 30% hydrogen peroxide in glacial 
acetic acid (AcOH) at 65 °C. Acetic anhydride (Ac2O) was added to the derivative 22 and refluxed 
to give 23 in 90% yield. Transesterification of the derivative 23 with anhydrous potassium 
carbonate in ethanol gave alcohol 24 in 87% yield. Alcohol 24 was oxidized to aldehyde 25 with 
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Figure 34: Synthetic route of 9-methyl-1,10-phenantroline-2-carbaldehyde, P1CHO. 
 
P2CHO was prepared from commercially available 8-aminoquinoline (26). A reaction between 8-
aminoquinoline (26) and crotonaldehyde ((2E)-but-2-enal) (27) in 70% sulfuric acid (H2SO4) in 
the presence of sodium iodide (NaI) gave derivative 28 in 62% yield (Fig. 35). The methyl group 
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3.2 GENERATION OF THE DCL THROUGH REVERSIBLE IMINE EXCHANGE 
One of the fundamental requirements for the generation of DCLs is the design of a system that 
involves the combination of two reversible processes; the reversible covalent bond formation 
and reversible non-covalent interactions. The work employed here presents implementation of 
the DCL concept involving a reversible imine exchange reaction between the backbone modified 
oligonucleotide ON1 and a set of aldehyde modified nucleobases (GCHO, CCHO, ACHO, TCHO) as 
shown in Figure 36. The selection of one nucleobase to be attached to the amino group on the 
backbone in a higher efficiency than the rest of the nucleobases was directed by DNA-
templating. The addition of a template to the reaction, with the intention of increasing the 
efficiency of one specific product, relies on the reversible non-covalent forces such as hydrogen 
bond formation. 
The imine-based libraries are often generated at mildly acidic pH and at room temperature.[83] A 
mildly acidic pH is high enough to provide sufficient free amine to attack the carbonyl group of 
the aldehyde, but low enough for protonation of the carbonyl oxygen prior to the nucleophilic 
attack and also for protonation of the resulting tetrahedral intermediate for elimination of 
water. In this work, all imine exchange reactions between ON1 and the aldehyde modified 
nucleobases (GCHO, CCHO, ACHO, TCHO) were performed at room temperature in 20 mM sodium 
phosphate buffer at pH 6 containing 1 M NaCl.  
For the purpose of this work, 13mer ON1 and one of the four 16mer complementary 
oligonucleotide template strands TC/G/T/A  (Table 3) were mixed in a 1:1 ratio, followed by the 
addition of an excess amount of all four aldehyde nucleobases GCHO, CCHO, ACHO, TCHO in 
equimolar or non-equimolar concentrations. The reaction mixtures were incubated for three 
hours at room temperature at pH 6. The aldehydes and the amine were allowed to react 
reversibly to form four intermediate imine products. The four possible imine products in the 
dynamic library under equilibrium are shown in Figure 36b. In addition, the intermediate imine 
products in equilibrium were subsequently reduced to amines (Fig. 36c). Thus, irreversible 
formation of amines facilitated the isolation and analysis of the equilibrated DCL. Reduction was 
performed by adding sodium cyanoborhydride (NaBH3CN) and shaking it for one hour. After 
reduction of the imine intermediates, there were four possible final amine products (ON1+G, 
ON1+C, ON1+A, ON1+T) (Fig. 36c). The proportions of imine products in the library should vary 
by altering the template strand, based on their affinity to the template strand. Addition of 




a `X´represents the abasic site with an amino group. 
b Nucleobases corresponding to the abasic site of the modified strand are shown in bold letters. 
c  The GTT sequence at 3'-end was added to extend the sequence to make it easier to separate through 
HPLC. 
 

























































































Library of Imine ProductsBuilding Blocks Library of Amine Products  
Figure 36: a) Initial building blocks; amine and aldehydes in the presence of the template. b) A dynamic 
combinatorial library of all possible imine products generated by reversible combinations of the starting 
materials. c) Library of amine products after reduction. 
 
Four template strands (TC/G/T/A) were used which were complementary to the ON1 but varying in 
their single nucleobase opposite to the amino group on ON1 (Table 3). Here, the capital letter 
index of T stands for the cytosine, guanine, thymine and adenine nucleobase positioning 
opposite to the amine on ON1. The template strands were used as 16mers where the ON1 was a 
13mer in order to achieve better seperations through HPLC. 
 
 
Oligonucleotide Sequence (5'-3')  
ON1 CGCTATXTATCGC a 








The efficiency and selectivity of the base incorporation were tested by altering the template 
strand in the reaction. Four reactions were employed in parallel, each includes one of the 




library for each template was analyzed by anion exchange HPLC (AE-HPLC)  and electrospray 





3.3 HPLC CONDITIONS FOR THE ANALYSIS OF DCL 
The challenging task of the applied DCC model system was the separation of the 
oligonucleotides in the library for their analysis. Prior to the analysis of the library, the reaction 
mixture was purified from the salts and excess of the aldehydes through gel filtration 
(Centri.Pure N10). The analysis of the purified final reaction mixture was performed by AE-HPLC 
with detection at 260 nm.  
Early studies involved the development of a method for the chromatographic separations of 
oligonucleotides in the DCL. The final reaction mixture contained a mixture of six 
oligonucleotides: the unreacted modified strand ON1, one of the template strand TC/G/T/A, and 
the four possible reductive amination products (ON1+G, ON1+C, ON1+A, ON1+T) resulting from 
the base incorporation (Fig. 36, Chapter 3.2). In this mixture, the four product strands and the 
unreacted ON1 were bound to the complementary template strand through hydrogen bonding. 
During the analysis of the reaction mixture by chromatography, it was necessary to break the 
hydrogen bonds in order to separate the oligonucleotides from the template strand. This could 
be achieved by performing the separation under denaturating conditions. There are two 
methods to restrict hydrogen bonding interactions between product strands and the 
complementary template strand; the denaturating conditions at high pH values up to 12 or at 
high temperatures up to 80 °C. Furthermore, the template strands were used as 16mer 
complementary sequences in order to elute them later than 13mer sequences. Thus, it was 
allowed to enlarge the distance of retention times between the oligonucleotide ON1 and the 
template strand.  
Besides the separation of the template strand from the rest of the oligonucleotides using 
denaturating conditions, the 13mer oligonucleotides had to be separated from each other. The 
starting sequence CGCTATXTATCGC (ON1) and the product sequences (ON1+G, ON1+C, ON1+A, 
ON1+T) had the same length differing only by one nucleobase in the central position `X´. The 
starting sequence (ON1) had a free amino group at position `X´ where the base-filled products 
were carrying one of the four nucleobases attached with an ethyl linker on the amino group. 
Since the oligonucleotides in the library had the identical length, their separation with the 
length-based reverse phase HPLC method was not suitable. When analyzing single stranded 
oligonucleotides of identical length, anion exchange chromatography is the method of choice to 
resolve the components based on interactions with hydrophobic bases. Thus, elution is 
influenced by the base composition of the same-length oligonucleotides. Since the 
 
 
oligonucleotides (ON1, ON1+G, ON1+C, ON1+A, ON1+T) differed in one nucleobase, the one 
positioning on `X´ would influence the elution order.  
During the anion exchange chromatographic seperations in this work, either elevated 
temperatures or elevated pH were used as denaturating conditions. The resolution of the peaks 
and the elution order of oligonucleotides were influenced by pH or temperature as well. For 
example, at pH 12 each G or T base contributes a negative charge from the deprotonated oxygen 
atoms and is eluted later than A and C bases. This could be an advantage for the elution of 
ON1+G and ON1+T. However, better resolution of the peaks for ON1, ON1+C and ON1+A was 
obtained when a high temperature was used. Elution conditions for each individual 
chromatogram are given individually after each experiment in Chapter 3.4. 
ESI-MS was employed for the characterization of the reaction products after their separation 
through HPLC. Desalting of the oligonucleotide was crucial for the ESI-MS analysis. The multiple 
adducts on the phosphate backbone of the oligonucleotide dramatically decreased the 
sensitivity and complicated the interpretation of the spectra. Desalting was performed manually 





3.4 ANALYSIS OF THE DCL 
 
3.4.1 EFFECT OF THE TEMPLATE 
 
In preliminary experiments, the attachment of a single nucleobase onto ON1 was investigated 
under reductive amination conditions. In order to investigate the effect of the template on the 
formation of the product, the guanine-aldehyde (GCHO) (1.3 mM) was added to a 1:1 mixture of 
ON1 (32 µM) and TC (32 µM) in phosphate buffer at pH 6. The reaction mixture was stirred for 
three hours at room temperature and then for reduction NaBH3CN (160 mM) was added and the 
mixture was further shaken for one hour. This reaction was repeated in the absence of the 
template strand (TC). This time, instead of the template strand, the same volume of phosphate 
buffer was added into the reaction in order to keep the reactions in same volume for a better 
comparison. After removal of the inorganic salts by gel filtration, reactions were analyzed with 
AE-HPLC under denaturating conditions at pH 12. HPLC profiles of the experiments in absence 
and in presence of the template strand TC are given in Figure 37. Comparison of the two 
chromatograms clearly indicated that in absence of a template strand, the peak for ON1 (8.5 
min) was not diminished and no new (or very tiny amounts) product formation was observed 
under the applied conditions (Fig. 37a). When the template strand (TC) was added, ON1 was 
completely consumed and a new peak gave rise corresponding to the mass of the guanine 
incorporated product (ON1+G) (10.9 min) (Fig. 37b). These results shows the strong influence of 
the template strand on the reaction. ON1+G was eluted later than ON1 because at pH 12 
guanine has an additional negative charge on its oxygen atom. Furthermore, the separation of all 
three peaks (ON1, ON1+G and TC) was achieved by denaturation. The use of a complementary 





Figure 37: Representative HPLC profiles after reductive amination between GCHO and ON1 in absence of 
the template strand (TC) (red) and in presence of the template strand (TC) (blue). Solvent system (A3) 
10 mM NaOH, pH 12; (B3) 10 mM NaOH, 1.25 M NaCl, pH 12. Gradient 35-70% B3. Final concentrations in a 
310 µL reaction volume (20 mM sodium phosphate buffer, 1 M NaCl, pH 6): 32 µM in ON1 and TC; 1.3 mM 
in GCHO; 160 mM in NaBH3CN.  
 
The same reaction of ON1 (32 µM) with GCHO (1.3 mM) in the presence of the template 
TC (32 µM) was repeated in three Eppendorf caps in parallel. The reaction mixtures were 
incubated at room temperature for one hour, two hours and three hours, respectively, before 
addition of NaBH3CN. After a cleaning process, the reaction mixtures were analyzed by AE-HPLC 
(Fig. 38). The formation of the guanine incorporated product (ON1+G) was observed after one 
hour but was not fully achieved. After three hours, the ON1 was completely converted into 
ON1+G. Hereafter, all further experiments for DNA-templated reductive amination were 






Figure 38:  Representative HPLC profiles after DNA-templated reductive amination between ON1 and GCHO 
with an incubation time of 1 hour (black), 2 hours (red) and 3 hours (blue). Solvent system (A3) 10 mM 
NaOH, pH 12; (B3) 10 mM NaOH, 1.25 M NaCl, pH 12. Gradient 35-70% B3. Final concentrations in a 310 µL 
reaction volume (20 mM sodium phosphate buffer, 1 M NaCl, pH 6): 32 µM in ON1 and TC; 1.3 mM in GCHO; 
160 mM in NaBH3CN.  
 
3.4.2 BASE-FILLING IN PRESENCE OF ONE NUCLEOBASE  
 
Having shown that guanine-aldehyde was efficiently bound to ON1 via reductive amination, the 
capacity of dynamic binding was tested also for cytosine, adenine and thymine aldehydes 
individually in the presence of the template strand. Four reactions were performed in parallel 
and in each ON1 (32 µM)  was allowed to react with one of the four nucleobases GCHO, CCHO, ACHO 
or TCHO (1.3 mM). To each of these mixtures, an appropriate template strand TC, TG, TT or TA (32 
µM) was added, respectively. As a template strand, one of the complementary strands of ON1 
was used, the one which has the complementary base of the added nucleobase-aldehyde 
opposite to the blank X position of ON1. In this way, the use of TC with cytosine as its templating 
base would direct the formation of guanine incorporation, likewise  TG of cytosine incorporation, 
TT of adenine incorporation and TA would direct the formation of thymine incorporation.  
AE-HPLC analyses were performed under denaturating conditions using high pH in order to 
break any hydrogen bonding between the template and library members. As shown in each 
chromatogram in Figure 39, 16mer templates were eluted at high retention times. It was 
possible to fully resolve the guanine and thymine incorporated products (ON1+G, ON1+T) from 
ON1 because at pH 12 these both nucleobases were negatively charged due to the 
deprotonated oxygen and they were eluted at high retention times compared to ON1 (Fig. 39a 




ON1+A were not clearly resolved and were eluted together with ON1 since cytosine and adenine 
contribute no additional negative charge due to the absence of deprotonated oxygen (Fig. 39b 
and c). However, the formation of the products ON1+C and ON1+A were proven by ESI-MS.  
 
 
Figure 39: Representative AE-HPLC (at pH 12) profiles after DNA-templated reductive amination. Solvent 
system (A3) 10 mM NaOH, pH 12; (B3) 10 mM NaOH, 1.25 M NaCl, pH 12. Gradient 35-70% B3. a) Reductive 
amination between ON1 and GCHO in the presence of TC; b) Redutive amination between ON1 and CCHO in 
the presence of TG; c) Reductive amination between ON1 and ACHO in the presence of TT; d) Reductive 
amination between ON1 and TCHO in the presence of TA. Final concentrations in a 310 µL reaction volume: 
20 mM sodium phosphate buffer, pH 6; 32 µM in ON1 and template strand; 1.3 mM in nucleobase 
aldehyde; 320 mM in NaBH3CN.  
 
As it is described in Chapter 3.3, pH and temperature have different influence on the elution of 
the oligonucleotides through anion exchange chromatography. In order to accomplish better 
elution for ON1+C and ON1+A, the HPLC elution conditions were changed. Therefore, elevated 
temperature (80 °C) was tried as elution conditions instead of elevated pH in order to break the 
hydrogen bonding with the template strand. At high temperature, better resolution of peaks 




separated effectively from all four product sequences (Fig. 40). Furthermore, the elution of 
ON1+C and ON1+A was efficiently achieved. The elution order due to increasing retention times 
of oligonucleotides was found to be as followed: ON1 < ON1+C  < ON1+A   < ON1+T < ON1+G.  
 
 
Figure 40: Representative AE-HPLC profiles (at 80 °C) after DNA-templated reductive amination for base-
filling in the presence of a single nucleobase. Solvent system (A2) 20 mM Tris-Cl, pH 8; (B2) 20 mM Tris-Cl, 
1.25 M NaCl, pH 8. Gradient 25-60% B2. a) Reductive amination between ON1 and GCHO in the presence of 
TC; b) Reductive amination between ON1 and CCHO in the presence of TG; c) Reductive amination between 
ON1 and ACHO in the presence of TT; d) Reductive amination between ON1 and TCHO in the presence of TA. 
Final concentrations in a 310 µL reaction volume: 20 mM sodium phosphate buffer, pH 6; 32 µM in ON1 
and template strand; 1.3 mM in nucleobase aldehyde; 320 mM in NaBH3CN. 
 
Conversion of ON1 into products was determined by a comparison of the HPLC peak areas of the 
product and the starting material (Table 4). The most successful incorporation was detected 
from the reaction between GCHO and ON1, where ON1 was nearly completely converted into the 
guanine incorporated product (ON1+G) (Fig. 40a). 6:1 ratio of the product to starting material 
ON1 was obtained (Table 4). Cytosine and adenine were incorporated in comparable but lower 
yields than the incorporation of guanine. When the thymine aldehyde was allowed to react with 




Table 4: Ratio of HPLC peak areas resulted from base-filling through DNA-Templated reductive 
amination. 
 
Based on these results, guanine was incorporated with higher yield due to its three hydrogen 
bonding capacity and higher π-stacking interactions. 
 
Figure 35 Reaction Templating Base Product Product:ON1 
A ON1+GCHO C ON1+G 6:1 
B ON1+CCHO G ON1+C 1:1 
C ON1+ACHO T ON1+A 1:1 
D ON1+TCHO A ON1+T 1:4 
 
In terms of these results, the four possible components of the library (ON1+C  , ON1+A  ,  ON1+T, 
 ON1+G) were synthesized separately and their retention times were determined on AE-HPLC. 
The identification of each product individiually were helpful for the understanding of further 
experiments in the presence of all four nucleobases in same reaction vessel. 
 
3.4.3 BASE-FILLING IN PRESENCE OF FOUR NUCLEOBASES 
 
The approach was further explored by including all four nucleobases in the same reaction vessel. 
Four reactions were performed in parallel and in each ON1 (32 µM) was allowed to react 
simultaneously with four nucleobase-aldehydes in equimolar concentrations: GCHO (1.3 mM), 
CCHO (1.3 mM), ACHO (1.3 mM), TCHO (1.3 mM). To each of these four mixtures one of the four 
template strands was added (TC, TG, TT or TA; each in 32 µM). The reaction mixtures were 
incubated at room temperature for three hours for the formation of the library of imine 
products. After three hours, the imines were reduced to the amines by addition of NaBH3CN. 
The composition of each library was analyzed by AE-HPLC. The effect of the template on the 
proportions of products in the amine-based library was investigated. The efficiency and 
selectivity of base incorporation in the presence of different templates was analyzed.  
With regard to previous results (Chapter 3.4.2), AE-HPLC was performed using a high 
temperature (80 °C) in order to achieve better resolution. High temperature allowed the elution 
of ON1 from the rest of the product strands which was not possible at high pH. As shown in 
Figure 41, in each case ON1 was eluted earlier than the rest, whereas templates were eluted at 
longest retention times. The presence of different templates gave different conversion of ON1. 
In presence of template TC, oligonucleotide ON1 was completely consumed and the highest 






Figure 41: Representative AE-HPLC profiles (at 80 °C) after DNA-templated reductive amination for base-
filling in the presence of all four nucleobases. Solvent system (A2) 20 mM Tris-Cl, pH 8; (B2) 20 mM Tris-Cl, 
1.25 M NaCl, pH 8. Gradient 25-60% B2. a) In the presence of TC; b) In the presence of TG; c) In the 
presence of TT; d) In the presence of TA. Final concentrations in a 310 µL reaction volume: 20 mM sodium 
phosphate buffer, pH 6; 32 µM in ON1 and template; GCHO (1.3 mM), CCHO (1.3 mM), ACHO (1.3 mM), TCHO 
(1.3 mM); 160 mM in NaBH3CN. 
 
All four products were eluted as a mixture of ON1 and the template. Although ON1 was 
efficiently separated, a second purification step was necessary for the separation of this mixture 
of products. Therefore, the mixture of the products (shown in Fig. 41 in a dot dashed rectangle) 
was collected and emposed to a second purification step by AE-HPLC but this time applying 
elevated pH as the method of denaturation. At high pH, the deprotonated oxygens of guanine 
and thymine were an advantage and better separation of the mixture into the four products was 






Figure 42: Representative AE-HPLC profiles (at pH 12) after DNA-templated reductive amination for base-
filling in the presence of all four nucleobases. Solvent system (A3) 10 mM NaOH, pH 12; (B3) 10 mM NaOH, 
1.25 M NaCl, pH 12. Gradient 35-70% B3. a) In the presence of TC; b) In the presence of TG; c) In the 
presence of TT; d) In the presence of TA. Final concentrations in a 310 µL reaction volume: 20 mM sodium 
phosphate buffer, pH 6; 32 µM in ON1 and template strand; GCHO (1.3 mM), CCHO (1.3 mM), ACHO (1.3 mM), 
TCHO (1.3 mM); 160 mM in NaBH3CN. 
 
In presence of the template TC (Fig. 42a), the peak which was corresponding to the mass of 
guanine incorporated product (ON1+G) was afforded. Only small amounts of other possible 
products were formed in comparison to ON1+G. This suggests that only one of the nucleobase 
amongst the four nucleobases was selectively incorporated into the oligonucleotide ON1 that 
stabilizes the duplex formed with complementary TC. Upon addition of template strand TG, rising 
of a new peak was observed containing the mass of the cytosine incorporated product ON1+C. 
TG induced the formation of cytosine incorporated product ON1+C. However, the selectivity of 
the cytosine incorporation was not as efficient as in case of guanine incorporation. In addition to 
the peak for ON1+C, the peaks for other mistemplated products were also identified. Amongst 
the mistemplated products, the guanine incorporated one (ON1+G) was obtained in higher 




for product ON1+A was resolved as the most favorable one. A reaction in which the templating 
base was replaced with TA, HPLC results showed that the formation of thymine incorporated 
product ON1+T was the least selective one. Even the formation of mistemplated cytosine and 
guanine products were more favorable than the formation of ON1+T. Based upon this data, it 
can be concluded that when a new template was added, the library reorganized itself by 
amplifying the most stable product at the expense of others. The product which had the 
strongest binding to the template was dominant in the library. However, the composition of the 
library does not necessarily consist of only the strongest bound product, but rather reflects a 
combination of products by arranging the whole system to the lowest energy. Thus, except 
selective incorporation of guanine through TC (Fig. 42a), in addition to the incorporation of the 
correct nucleobase, mistemplated products were also observed. However, in absence of a 
template no product formation was observed. 
Concisely, in the presence of a suitable template, guanine was incorporated more selectively 
than cytosine, adenine and thymine. The efficiency of the thymine incorporation was the lowest 
amongst all four nucleobases. Because of the elution of the peaks with a close distance, a 
comparison between adenine and cytosine in their efficiency and selectivity could not be 
determined. However, a better selectivity of cytosine than adenine can be predicted due to the 
higher numbers of hydrogen bonds of cytosine and guanine compared to adenine and thymine. 
Furthermore, due to higher π-stacking, guanine incorporation was more efficient than cytosine 
and likewise, adenine incorporation was more efficient than thymine.  
In order to have a better understanding of the reasons behind the selectivity, the duplex 
stabilities for ON1+G, ON1+C, ON1+A were investigated (unfortunately, ON1+T was excluded 
from this experiment because of not having enough sample). A series of melting temperature 
experiments were conducted for duplexes of ON1+G, ON1+C, ON1+A with their complementary 




Table 5: Melting temperatures of the products ON1+G, ON1+C, ON1+A with their complementary 
strands TC, TG, TT. 
a Herein the capital letter under X stands for the guanine, cytosine and adenine incorporated 
products. 
b The GTT sequence at 3'-end was removed from the templates TC, TG and TT for melting 
temperature experiments. 




Figure 43: Melting curves for the duplex formation for the products ON1+G, ON1+C, ON1+A with their 
complementary strands TC, TG, TT . (2,5 µM ds-DNA, 10 mM sodium phosphate buffer, pH 7, 100 mM NaCl). 
 
 
It can be apparently seen that, the highest melting temperature was obtained for 
ON1+G followed by ON1+C and ON1+A, respectively. This provides further confirmation 





Duplex Sequencea, b Tm/°C c 
ON1+G∙TC 5'-d(CGCTATXGTATCGC)-3'∙ 5'-d(GCGATACATAGCG)-3' 46.2 (34.1) 
ON1+C∙TG 5'-d(CGCTATXCTATCGC)-3'∙ 5'-d(GCGATAGATAGCG)-3' 44.7 (35.5) 




Prior to that, the duplex melting temperature of ON1 with its complementary strands was 
measured and the results specified (Table 2, Chapter 3.1.1.3) the insertion of a threoninol linker 




abasic site disturbed the backbone. However, the filling of the abasic site with one of the 
nucleobase raised the Tm about 10 °C higher than the ON1. 
 
3.4.4 BASE-FILLING IN PRESENCE OF NON-EQUIMOLAR AMOUNTS OF NUCLEOBASES 
 
According to Le Chatelierʼs principle, changing the starting concentrations of the nucleobase-
aldehydes would change the composition of the products in the dynamic library. In order to 
increase the selectivity of the nucleobases which were incorporated in lower yields under 
equimolar conditions, the initial concentrations of those nucleobase-aldehydes were increased. 
ON1 (32 µM) was allowed to react with four nucleobase-aldehydes in concentrations GCHO 
(1.3 mM), CCHO (1.7 mM), ACHO (2.3 mM), TCHO (4.3 mM).  
The change in the starting concentrations of the nucleobase-aldehydes resulted in a change in 
the proportions of the products in the library (Fig. 44). The peak for the favourable product had 
the highest intensity in each case. However, an increase in the concentration of the nucleobase-
aldehydes resulted in an increase in the formation of the mistemplated products as well. 
Guanine incorporation was still selective even in the presence of excess concentrations of the 
other nucleobase-aldehydes (Fig. 44a). Although the formation of the favourable products for 
cytosine and adenine incorporation was observed, the formation of mistemplated products was 
unavoidable. Due to the high concentration of thymine-aldehyde, the efficiency in the formation 
of thymine incorporated product in the presence of TA was increased in comparison to the same 





Figure 44: Representative AE-HPLC profiles (pH 12) after DNA-templated reductive amination for base-
filling in the presence of all four nucleobases. Solvent system (A3) 10 mM NaOH, pH 12; (B3) 10 mM NaOH, 
1.25 M NaCl, pH 12. Gradient 35-70% B3. a) In the presence of TC; b) In the presence of TG; c) In the 
presence of TT; d) In the presence of TA. Final concentrations in a 310 µL reaction volume: Final 
concentrations in a 310 µL reaction volume: 20 mM sodium phosphate buffer, pH 6; 32 µM in ON1 and 
template strand; GCHO (1.3 mM), CCHO (1.7 mM), ACHO (2.3 mM), TCHO (4.3 mM); 160 mM in NaBH3CN. 
 
3.4.5 TEST OF REVERSIBILITY 
 
In order to investigate the reversibility of the nucleobase incorporation, in the absence of the 
guanine-aldehyde (GCHO), the cytosine-, adenine- and thymine-aldehydes (CCHO, ACHO and TCHO) 
(1.3 mM) were added to a 1:1 mixture of ON1 (32 µM) and TC (32 µM). Reaction mixture was 
stirred for three hours at room temperature and GCHO was added into this reaction mixture 





Figure 45: Representative AE-HPLC profiles after DNA-templated reductive amination for base-filling in the 
presence of GCHO (red) and in the absence of GCHO (black). Solvent system (A2) 20 mM Tris-Cl, pH 8; (B2) 20 
mM Tris-Cl, 1.25 M NaCl, pH 8. Gradient 25-60% B2. 
 
Reaction in the absence of guanine-aldehyde resulted in the formation of cytosine, adenine and 
thymine incorporated products (Fig. 45b). Upon addition of the GCHO, the incorrect products 
were corrected through the formation of guanine incorporated product (ON1+G) (Fig.45a). This 
result indicated the adaptive and flexible nature of the dynamic library and the reversibility of 
the selection process. 
 
3.4.6 ABASIC TEMPLATING 
 
Abasic sugar sites are common type of lesion in DNA.[130] Due to its biological importance, there 
is a strong investigation for recognizing the abasic sites in DNA for diagnostic applications.[131] As 
a part of those investigations, the use of aromatic residues with large π-surfaces opposite to the 
abasic site in order to stabilize the duplex DNA has been reported.[132,133] An abasic site in an 
oligonucleotide duplex causes a distortion because of lack of continuity of the base stacking.[131] 
It has been reported that a complemantary oligonucleotide with flat, aromatic residues opposite 
to the abasic site can be used to stabilize the oligonucleotide duplex.[129] The aromatic residues 
can compensate the missing nucleobase by providing the aromatic stacking within the duplex. 
Thus, nucleosides carrying pyrene and other polyaromatic hydrocarbons have been used in 
order to compensate the missing nucleobase.[134] Furthermore, the use of non-nucleosidic 
phenanthrene and phenantrolines as base surrogates has been reported to stabilize the abasic 




By taking this into consideration, ,10-phenantroline-2-carbaldehyde (P2CHO) was used in dynamic 
incorporation reactions in order to investigate the effect of an abasic site in the template strand. 
A DNA template (TP) which had an abasic ribose moiety opposite to the acyclic site of ON1 was 



























Figure 46: The use of abasic DNA template  for the reversible incorporation of nucleobase-aldehydes, 
GCHO, CCHO, ACHO and TCHO and phenantroline-aldehyde P2CHO.  
 
In a reaction where the P2CHO together with GCHO, CCHO, ACHO and TCHO (each in 1.3 mM) were 
added into a 1:1 mixture of ON1 (32 µM) and the abasic template TP (32 µM) showed the 
selective incorporation of P2CHO (Fig. 47). 
 
 
Figure 47: Representative AE-HPLC profiles after DNA-templated reductive amination for base-filling in the 
presence of P2CHO. Solvent system (A2) 20 mM Tris-Cl, pH 8; (B2) 20 mM Tris-Cl, 1.25 M NaCl, pH 8. 
Gradient 25-60% B2. 
 
Phenantroline incorporated product (ON1+P) eluted in shorter retention times than ON1. The 
analysis of the peak of ON1+P by ESI-MS showed a mass difference of a m/z = +60. That might be 




Chelex®-100 resin in order to remove all metal residues coordinated during the synthesis and 






3.5 DISCUSSION  
The dynamic imine library between the primary amine on a pre-formed DNA backbone and a 
pool of monomeric nucleobase-aldehydes was established in presence of a complementary DNA 
template. The four possible products, which resulted from the incorporation of the four 
nucleobases, in the imine library were analyzed after their subsequent reduction to an amine 
library. As analysis method anion exchange-HPLC and ESI-MS was chosen. The combination of 
these two techniques enabled the separation of the species in the library followed by their 
identification. The separation by HPLC gave convenient information about the number of 
different products present in the library. The subsequent analysis of the HPLC output by ESI-MS 
identified each of the detected species. In order to discuss the relative amounts of each product 
in the library, the ideal HPLC seperations should include better resolution of the peaks. If this 
prerequisite could be fulfilled, ratio of the composition of any library member could be 
quantified by a comparison of the peak areas. If the relative amounts of each product could have 
been obtained, a better discussion on the selectivity for each nucleobase could be given. For all 
that, with the analysis method applied in this thesis, any change in the proportion of the 
products could be successfully proven from the peak intensities. In short, the advantage of DCC 
is in that it allows an easy synthesis of a large range of compounds which are closely related in 
terms of molecular reactivity and structure. This advantage can turn into a limitation at the point 
of analyzing the library composition. 
The attempt attaching nucleobases to the abasic site on DNA backbone showed no product 
formation in the absence of a DNA-template. However, under same conditions the addition of a 
DNA-template into the reaction enabled the attachment of the nucleobases on the abasic site. 
The correct nucleobase amongst four nucleobases was selectively chosen by the DNA template 
through Watson-Crick base pairing and stacking interactions. Four imine products were formed 
but the one with the correct hydrogen bonding with the template was the most stable one, so 
the most dominant one. When a new template was added, the change in the ratios of the 
products in the library showed the adaptive nature of the library. This further indicates the role 
of the template in the selection process of the nucleobases. The attachment of guanine in the 
presence of an appropriate template proceeded with good yields and good selectivity. Only 
small amounts of mistemplated product was observed. Attachment of cytosine, adenine and 
thymine in presence of their templating bases, showed tendency in the formation of the 
favourable product, however, the selectivity was not as high as the attachment of guanine. 
Mistemplated products were observed in higher proportions during the incorporation of 
adenine, cytosine and thymine. The highest selectivity was observed for the guanine 
 
 
incorporation and this has been attributed to the greater numbers of hydrogen bonds. The 
lowest selectivity was observed for the thymine incorporation probably due to the formation of 
only two hydrogen bonds with the templating base. Since the cytosine and adenine incorporated 
products were eluted in a close distance to each other, it was difficult to determine their 
selectivities. A better selectivity can be predicted for the cytosine than adenine due to the 
number of hydrogen bonds. Stacking interactions play also a role in the selectivity besides the 
hydrogen bonds. Purine bases were incorporated with better yield and greater selectivity than 
pyrimidines (G>C>A>T). 
Following Le Chateliers`s principle for the library in dynamic equilibrium, the starting 
concentration of the thymine was increased because thymine was the least selectively 
incorporated nucleobase. The increased starting concentrations of thymine nucleobase aldehyde 
resulted in an increased change in the ratio of thymine incorporated product. On the other 
hand, the ratio of mistemplated thymine products was also increased. In future studies, the 
starting concentration of the bases could be optimized to improve the selectivity of the 
incorporation.  
An interesting result was obtained from a reaction in which a DNA template that had an abasic 
site at the templating position. In this case P2CHO was incorporated in better yields. Those results 
had been attributed to the stacking interactions of phenantroline.[135] 
Prior to this thesis, two similar studies were carried out using imine exchange reaction to fill the 
abasic sites on PNA using nucleobase-aldehydes by LIU and co-workers and by BRADLEY and co-
workers.[97,115] Although the imine chemistry employed in this thesis is the same with the 
previously published works, herein the use of a DNA backbone with amine group for base filling 
approach instead of PNA backbone presents a new approach for DCC applications to 
oligonucleotides. In their works MALDI-MS was used for the analysis which enabled the 
quantification of the selectivities of the nucleobases by comparing the intensities of the 
products. BRADLEY and co-workers extended the application to the genetic analysis.[115] They 
were able to analyze the sequence of the complementary DNA template through selective 
incorporation of nucleobases on the PNA abasic positions. 
The results obtained from their published works, provided further confirmation to the results 
presented in this thesis for the selectivities for four nucleobases. Guanine and cytosine were 
incorporated more selectively than either adenine and thymine. Furthermore, purine bases were 
incorporated more selectively than pyrimidines due to the greater stacking interactions. In their 




thesis the proportions of the mistemplated products in the composition of the library were 
observed in significant ratios.  
For future studies, the ability of base-filling can be extended on a DNA backbone that has two or 
more neighbouring blank positions. But a better optimization for the here applied HPLC method 
would be necessary. The dynamic base-filling reactions on DNA/DNA duplex can be extended to 
genetic analysis by a direct read-out with MALDI-MS. Furthermore, oligonucleotides with thiol 
functional groups on the backbone can be used to investigate another reversible reaction like 
thioester exchange process based on dynamic combinatorial chemistry. 
The dynamic chemistry assay described here can be applied using labelled nucleobase-aldehydes 
and their subsequent analysis by fluorescence detection. On the other hand, not only natural 







4  DNA-BASED CATALYSIS 
 
The incorporation of transition metal complexes into DNA is an important objective for the 
development of DNA-based hybrid catalysts. The metal complexes can bind to DNA via 
noncovalent and covalent attachment. So far, the covalent incorporation of the transition metal 
complexes into DNA sequence was mostly considered at the 5'- or 3'-end or internally, either at 
the nucleobase or at the ribose 2'-position.[136,137] In this chapter, the post-synthetic, covalent 
incorporation of the phenantroline (phen) ligand to the acyclic backbone of DNA is described. By 
anchoring an achiral 1,10-phenantroline-copper(II) complex into dsDNA, we aimed to generate a 
novel DNA-based catalyst in order to investigate its performance in the copper(II)-catalyzed Diels-




















4.1 CONCEPT OF DNA-BASED HYBRID CATALYSIS 
 
Apart from template-directed reactions, another application of DNA is the use of double-
stranded DNA as a stereochemical control element in enantioselective reactions.[19,138] In this 
role of DNA as stereocontrol element, DNA does not behave directly as a catalyst but provides a 
chiral environment in asymmetric reactions.[19] This catalytic ensemble requires the use of an 
achiral metal ligand together with DNA. The catalytically active transition metal ligand is non-
covalently or covalently anchored to the DNA double helix for the assembly of DNA-based hybrid 
catalysis. Although the ligand is achiral, the corresponding metal complex with DNA is chiral. 
Thus, in a catalytic process, the metal coordinated ligand provides the catalytic activity and the 
DNA provides the enantioselectivity by its secondary coordination sphere. With this approach, 
the catalytic reaction takes place in, or very closed to the chiral DNA helix structure. The chirality 
is transferred from the DNA to the catalyzed reaction and enables the preferred formation of 
one of the enantiomers of the reaction products in excess.  
Among applications of asymmetric reactions, a series of DNA-based catalysis has been 
developed, which use a hybrid catalyst composed of dsDNA and a copper(II) complex.[121,139,140] 
The catalytic activity was investigated in a copper catalyzed Diels-Alder reaction in water.[141–144] 
The application shows that the use of DNA-based hybrid catalysts leads to high 
enantioselectivity, whereas in the absence of DNA, the corresponding products are obtained as 
racemats.  
Recently, a DNA-based asymmetric catalysis approach was introduced by ROELFES and co-
workers.[143] In their modular assembly three oligonucleotides are used (Fig. 48a): The first 
oligonucleotide is functionalized with 2,2'- bipyridine at the 5'-end phosphate group (Oligo 1); 
the second oligonucleotide (Oligo 2) is an unfunctionalized oligonucleotide and the third 
oligonucleotide is the template strand complementary to both oligonucleotides (Oligo 1 and 
Oligo 2). Using their chiral catalyst, the copper catalyzed Diels-Alder reaction between α,β-
unsaturated 2-acylpyridine (aza-chalcone) and cyclopentadiene was investigated (Fig. 48b). The 
reaction between 30 and 31 (Fig. 48) gives four products: two enantiomeric endo products (32) 
and two enantiomeric exo (33) products. In absence of the DNA-based catalyst, the reaction 
products were racemic however with the use of their DNA-based catalytic approach, moderate 
to good enantiomeric excess (ee) was achieved: 71% conversion of 31 to endo and exo products 
and 93% ee for the major isomer (endo). Therefore, it is clear that the enantioselectivity of the 
reaction came from DNA. However, the mechanism behind that, the induction of the DNA and 


































Figure 48: a) Schematic representation of the assembly of the DNA-based catalysts used in the work of 
ROELFES and co-workers.[143] b) Diels-Alder reaction between aza-chalcone (31) and cyclopentadiene (30) to 





4.2 POST-SYNTHETIC INCORPORATION OF PHENANTROLINE TO OLIGONUCLEOTIDES 
 
The first part of this thesis (Chapter 3) describes the incorporation of a D-threoninol-based acylic 
linker into the oligonucleotide strand in order to generate a ribose free, acyclic site in the 
backbone and its subsequent application in dynamic combinatorial chemistry. The presence of 
the reactive amino group on the backbone of the modified oligonucleotide enables its further 
functionalization by tethering appropriate functional molecules such as metal ligands. Metal 
ligands can be post-synthetically tethered, with a carboxyl group irreversibly or with an aldehyde 
group reversibly, to the amino group on the modified oligonucleotide. During the dynamic 
chemistry process which was applied in the first part of this thesis, the reversible attachment of 
the aldehyde modified phenantroline (P2CHO) on the modified oligonucleotide ON1 in the 
presence of a complementary template strand was described. The template-directed 
incorporation of the phenantroline ligand to the specific position on the DNA was recalled here 
in Figure 49. The covalent attachment of the metal ligand (P2CHO) through reductive amination 
has been accomplished by post-synthetic functionalization. After succesful incorporation of the 
phenantroline ligand (P2CHO) to the ON1, the single stranded ON1+P was separated from 
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Figure 49: The template-directed attachment of the phenantroline-aldehyde ligand to the amino group on 
the ON1 through reductive amination. TP is the complementary template strand with an abasic site 






4.3  ASSEMBLY OF DNA-BASED METAL COMPLEX  
 
In order to design a DNA-based catalysis, a metal ligand is post-synthetically attached to the DNA 
via a covalent linkage. Subsequent hybridization in the presence of a metal salt allows the DNA-








Figure 50: Schematic representation of the assembly of the DNA-based catalyst.(redrawn from [145]) 
 
The copper coordinated DNA-based system was assembled by thermal annealing of the 
equimolar amounts of ON1+P and its complementary strand (Tp) in the presence of copper(II) 
salt as shown in Figure 51. The aqueous solutions of ON1+P (12 nmol) and Tp (12 nmol) were 
mixed together and freeze-dried. To the freeze-dried mixture of the oligonucleotides, a solution 
of copper(II) nitrate trihydrate (Cu(NO3)2∙3H2O) (12 nmol) in annealing buffer (10 mM Tris, pH 7) 
was added. The solution was heated up to 80 °C and then cooled down slowly to room 
temperature. Hybridization in the presence of the metal ion gave rise to the formation of the 
duplex DNA and the catalytically active metal complex is positioned internally. After the 
annealing process, the double-stranded ON1+P (dsON1+P) was passed through a gel filtration 
column in order to remove excess of copper salts. The dsON1+P coordinated with copper metals 

































After annealing, the melting temperature was determined for dsON1+P (Fig. 52) and showed 
that the system remained hybridized. The melting temperature of the duplex was determined as 
33.8 °C.  
 
 
Figure 52: Melting curve for the DNA-based phenantroline catalyst coordinated with copper (dsON1+P). 
(2,5 µM ds-DNA, 10 mM sodium phosphate buffer, pH 7, 100 mM NaCl). 
 
For the DNA-based 1,10-phenantroline-copper(II) complex (dsON1+P), circular dichroism (CD) 
measurements showed a positive ellipticity maximum at 275 nm and negative minimum at 
around 250 nm with a crossover around 260 (Fig. 53). This corresponds to the typical B-DNA 
structure and suggests the modification did not change the structure of DNA assembly. 
 
Figure 53: CD spectrum for the DNA-based phenantroline catalyst (dsON1+P). (5 µM ds-DNA, 10 mM 






4.4 APPLICATION OF DNA-BASED CATALYSIS IN DIELS-ALDER REACTION 
 
Herein, the catalytic performance of dsON1+P was tested in a Diels-Alder reaction between aza-
chalcone (31) and cyclopentadiene (30) under same conditions as described in literature known 
applications (Fig. 48).[142,143]  
 
In an initial experiment, the reaction was carried out in absence of the DNA-based catalyst, 
dsON1+P. The aza-chalcone in acetonitrile (31) (120 nmol) and the excess of cyclopentadiene 
(30) (1.20 mmol) were mixed in MOPS buffer (20 mM, pH 6.5) in the presence of Cu(NO3)2 (12 
nmol, 10 mol%). Reaction was perfomed at 5 °C. The reaction mixture was observed at various 
time scales by HPLC and results are given in Figure 53. After one day, the peak for aza-chalcone 
(31) was still there and the formation of the endo and exo products (32-33) was observed only in 
small amounts (Fig. 53a). After three days, the peak for aza-chalcone (31) was decreased and the 
formation of a new peak for the products (32-33) was obtained (Fig. 53b). Hereafter, further 
experiments between aza-chalcone and cyclopentadiene were performed with a reaction time 
of three days. The conversion of 31 (81%) into products (32-33) with a reaction time of three 
days was determined by a comparison of the HPLC peak areas of the product and the starting 
material (Table 6). The peak for the products 32-33 was collected and analyzed by chiral HPLC in 
order to determine the diastereoselectivity (endo:exo) and enantiomeric excess (ee) according 
to literature (Table 6).[143,146]  
No product formation was observed in a reaction between aza-chalcone and cyclopentadiene in 






Figure 53: Representative RP-HPLC profiles of the Diels-Alder reaction between aza-chalcone (31) and 
cyclopentadiene (30) in order to afford endo and exo products (32-33). Solvent System (A4) H2O, 0.1% 
TFA; (B4) MeOH, 0.1%TFA. Gradient 50-100% B4. a) Diels-Alder reaction after one day in the presence of 
Cu(NO3)2; b) Diels-Alder reaction after three days in the presence of Cu(NO3)2; c) Diels-Alder reaction 
after three days in the absence of Cu(NO3)2.  
 
In the next step, the same reaction was carried out in the presence of DNA-based catalyst 
(dsON1+P) (12 nmol, 10 mol%) by mixing azachalcone (120 nmol) and excess of cyclopentadiene 
(1.20 mmol) in MOPS buffer (20 mM, pH 6.5). Reaction was perfomed at 5 °C in order to keep the 
double-stranded oligonucleotide in its hybridized form. After three days, the reaction mixture 
was analysed by RP-HPLC (Fig. 54). The conversion of the aza-chalcone (31) to the endo and exo 
products (32-33) by a comparison of the HPLC peak areas was calculated as 60% (Fig. 54). The 
use of DNA-based catalyst (dsON1+P) resulted with a low conversion (60%) than that of the 




Table 6: Diels-Alder reactions catalyzed by Cu(NO3)2 or DNA-Cu
2+ complex. 
a Determined by RP-HPLC peak areas of aza-chalcone (31) and the products (32-33). 




Figure 54: Representative RP-HPLC profiles after Diels-Alder reaction between aza-chalcone (31) and 
cyclopentadiene (30) in order to afford endo and exo products (32-33). Diels-Alder reaction after three 
days in the presence of dsON1+P. Solvent System (A4) H2O, 0.1% TFA; (B4) MeOH, 0.1%TFA. Gradient 50-
100% B4. 
 
The eluted peaks for the products 32-33 were collected and analyzed by chiral HPLC in order to 
determine the diastereoselectivity (endo:exo) and enantiomeric excess (ee). However, the use of 




Catalyst Conversiona (%) endo:exoa eeb 
Cu(NO3)2 81 93:7 0 










The covalent attachment of the phenantroline based metal ligand to the backbone of the DNA 
resulted in the formation of a DNA-based catalyst. This DNA-based catalytic system was used in a 
Cu2+ catalyzed Diels-Alder reaction in water. Although 60% conversion was obtained, no 
enantioselectivity in the product of the reaction was observed. Inspite of the results obtained 
here, further studies are necessary to obtain enantioselectivities in asymmetric reactions. 
Most challenging but time-consuming part in this work was the design of the DNA-based metal 
complex including the covalent attachment of the ligand to the oligonucleotide and its 
coordination to the copper. Even though one application of the DNA-based metal complex in 
Diels-Alder reaction was shown, more studies and efforts should be made for catalytic 






With the growing field of DNA technology there is an increasing demand for new modifications 
of DNA, which improve its versatility and promote the DNA as a fundamental scaffold for a wide 
field of applications like catalysis, encoding processes and supramolecular functionalized 
structures.  
The research described in this thesis includes the preparation of a modified oligonucleotide and 
is then focused on the functionalization of this modified oligonucleotide by a dynamic 
combinatorial chemistry approach. For the modification of the oligonucleotide, the ribose unit of 
the backbone in the native structure of DNA was replaced by D-threoninol. In order to achieve 
this purpose, in the first step D-threoninol (1) was successfully converted to the phosphoramidite 
monomer 4 with an orthogonal protected amino group (Fig. 55). The corresponding 
phosphoramidite monomer 4 was necessary in order to make it suitable for automated DNA 
synthesis. It was successfully incorporated into the central position of a 13mer oligonucleotide 












































Figure 55: Phosphoramidite monomer 4 was incorporated into oligonucleotides via automated synthesis 
on a solid support. 
 
The advantage of the reactive amino group on the backbone of the modified oligonucleotide 
was that any functional molecule of interest functionalized as an aldehyde can be easily tethered 
into the oligonucleotide post-synthetically. In this work the natural nucleobases were 
synthesized with aldehyde groups (Fig. 56) to allow them to reversibly react with the free amino 
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Figure 56: A set of aldehyde modified nucleobases, GCHO, CCHO, ACHO, TCHO. 
 
This thesis is an example for the dynamic combinatorial chemistry approach applied to 
oligonucleotides demonstrating the selective attachment of aldehyde-modified nucleobase units 
to the abasic site of the double-stranded-oligonucleotide. This was achieved by allowing the 
modified oligonucleotide to react with four nucleobases through reversible imine formation in 
the presence of a complementary template strand. In the presence of four nucleobases, four 
possible imine products were obtained in the dynamic library but one of them was more 
dominant with respect to others. The correct nucleobase which paired with the nucleotide of 
the template strand according to Watson-Crick base pairing had the strongest binding to the 
template and was the dominant one in the library (Fig. 57). However, the composition of the 
library did not necessarily consist of the singly most strongly bound product, but rather reflected 
a combination of products by arranging the whole system. It was interesting to see that when a 
new template was added, the library reorganized itself by amplifying the most stable product at 
the expense of others. The results demonstrated the adaptive and flexible nature of the dynamic 
library. The dynamic library was proven to be responsive to the external influences that alter the 



























































































































































































Backbone modified DNA Template DNA
Figure 57: Schematic representation of the model system used in this work in order to functionalize the 
backbone modified oligonucleotide through dynamic chemistry approach. The selection of a guanine 
nucleobase through a complementary template strand including cytosine in its sequence. G for guanine, C 





The composition of the dynamic library was investigated by anion exchange-HPLC and 
subsequent ESI-MS analysis. The number of hydrogen bonds and the stacking interactions played 
an important role in the selectivity of the nucleobases. The higher selectivity was observed for 
the guanine and cytosine than adenine and thymine due to their higher number of hydrogen 
bonds. Furthermore, purine bases were incorporated with better yield and greater selectivity 
than pyrimidines (G>C and A>T). 
Not only nucleobases but also a metal ligand with π-surface was attached to the same modified 
oligonucleotide in order to gain a new function to the DNA. To achieve this purpose 1,10-
phenantroline was functionalized as an aldehyde 29 (Fig. 58). Afterwards, the phenantroline 
ligand 29 was successfully attached to the amine of the modified oligonucleotide in presence of 
the template strand. In future works, various phenantroline-based ligands with extended π-
surfaces can be prepared in order to attach them to the backbone of the modified 
oligonucleotide. Dynamic combinatorial chemistry is a promising approach for the selection and 
screening of the best bound ligand. 
Furthermore, the phenantroline attached oligonucleotide was annealed with its complementary 
strand in the presence of copper ions in order to generate a DNA-based metal complex 
dsON1+P. Finally, this DNA-based metal complex was used as catalyst in an application for an 
enantioselective Diels-Alder reaction. In presence of Cu(II) catalyst (Cu(NO3)2), the Diels-Alder 
reaction between a diene and dienophile gave products in racemic fashion. In a second reaction, 
the DNA-based hybrid catalyst dsON1+P instead of free copper salts was used in order to obtain 
the products with enantiomeric stereoselectivity. However, the use of DNA-based hybrid 
catalyst dsON1+P did not show the predicted enantioselectivity in the reaction. The aim of 
designing an efficient enantioselective DNA-based catalyst was not completed due to time 























6. EXPERIMENTAL PART 
6.1 MATERIALS AND GENERAL INFORMATION 
 
Reagents Unless otherwise stated, reagents were supplied by Fluka (Taufkirchen, 
Germany), Sigma-Aldrich (Taufkirchen, Germany), Acros-Organics (Geel, Belgium), Merck 
(Darmstadt, Germany), ABCR (Karlsruhe, Germany), Fischer Scientific (Nidderau, Germany) and 
Alfa Aesar (Karlsruhe, Germany)  as analytical grade and used without further purification.  
 
Solvents Solvents for flash chromatography (ethyl acetate, pentane, methanol, 
dichloromethane) were distilled prior to use. Dry solvents were supplied by Acros-Organics 
(Geel, Belgium), Sigma-Aldrich (Taufkirchen, Germany) or Fluka (Taufkirchen, Germany). Dry 
solvents were stored over molecular sieves (4 Å). Acetonitrile (HPLC-grade) was obtained from 
VWR International. Ultra pure water (Milli-Q water) generated using water purification device 
Simplicity (Millipore, Bedford, UK).  
 
Reactions  All air and water sensitive reactions were performed under inert atmosphere 
using standard schlenk technique. Prior to the moisture sensitive reactions the glassware 
apparatus was dried by heating under vacuum followed by cooling to room temperature and 
flushed with dry argon. This process was repeated for three times.  Microwave reactions for acid 
hydrolysis were performed using a Discover microwave (MW) with a reaction cavity (CEM). 
 
Freeze-drying  Freeze-drying (lyophilization) of compounds from aqueous solutions 
containing was performed using a Christ-Alpha-2-4 lyophilizer attached to a high vacuum pump. 
For lyophilization of small amounts in Eppendorf caps, an evacuable Christ RCV-2-18 
ultracentrifuge connected to the lyophilization device was used. All solutions were frozen with 









6.2 CHROMATOGRAPHY  
 
Thin Layer Chromatography (TLC)  
TLC was performed on aluminium-backed Merck silica gel 60 F254 plates (layer thickness: 0.20 
mm). The spots were detected by fluorescence quenching at 254 nm. Non-fluorescence 
quenching compounds were detected using a ninhydrine solution in ethanol (3.0 g ninhydrine, 
100 mL ethanol). Aldehyde and acetal products were visualized using 2,4-dinitrophenylhydrazine 
solution (60 mL H2SO4, 80 mL H2O, 200 mL 95% ethanol). 
 
Flash Column Chromatography 
The chromatographic separations were carried out by the fritted glass column using Merck silica 
gel 60 (particle size: 40-60 μm) at 0.4-1.0 bar pressure. The columns were packed with wet silica 
gel. The quantity of silica gel was in relation with the weight of the substance to be purified 
(70-100 fold weight excess). All compounds were either adsorbed on silica gel before loading or 
loaded as a concentrated solution in the same solvent used as an eluent. Eluents are mentioned 
in each individual protocol in Chapter 6.6. 
 
Reverse Phase-High Performance Liquid Chromatography (RP-HPLC) 
Reverse Phase (RP)-HPLC analysis were performed on different devices: (i) a Pharmacia Äkta 
basic (GE Healthcare, London, UK) with a pump type P-900, variable wavelength detector UV-
900; (ii) a JASCO system (Jasco, Groß-Umstadt, Germany) equipped with two pumps 
PU-2080Plus, a diode array multi wavelength detector MD2010Plus a 3-line degasser 
DG-208053. UV absorption for oligonucleotides was detected at 260 nm.  
Oligonucleotides were analyzed using the following columns using flow rates 1 mL/min for 
analytic purification and 3 mL/min for semi-preparative purification: Macherey Nagel Column, 
EC 250/4.6 Nucleodur 100-5 C18ec (analytic), Macherey Nagel Column, VP 250/10 Nucleodur 
100-5 C18ec (semi-preparative). Oligonucleotides were eluted using buffer solutions. Buffer 
solutions were prepared by using Milli-Q water. As elution buffer a solvent system was 
employed; solvent A1 (0.1 M TEAA, pH 7.0) and solvent B1 (MeCN/TEAA (0.1 M, pH 7.0), 70:30) 
with a gradient of B1 from 5% to 60% over 30 min. The fractions containing desired product 
were collected and lyophilized.  
The products of Diels-Alder reaction were analyzed using the following column using flow rate 1 
mL/min for analytic purification: As eluents a solvent system was employed; solvent A4 (H2O, 





The enantiomeric excess was determined by chiral HPLC using a Daicel CHIRALCEL OD column 
(250 × 4.6 mm) with the eluents hexane/2-propanol (98/2), flow 0.5 mL/min. Retention times: tR 
= 14.1, 15.9 (exo isomer); tR = 18.5, 22.9 (endo isomer). 
 
Anion Exchange-High Performance Liquid Chromatography (AE-HPLC) 
Anion Exchange (AE)-HPLC analysis were performed on a micro HPLC, a JASCO system equipped 
with two pumps PU-2080Plus, a diode array multi wavelength detector MD2010Plus, a column 
thermostat CO-2060Plus and an autosampler unit AS-2055Plus. UV absorption for 
oligonucleotides was detected at 260 nm. Oligonucleotides were analyzed by using the DNAPac 
PA200 4x5 mm, DIONEX Ionexchange column with a flow rate 1 mL/min for analytic purification. 
Oligonucleotides were eluted using buffer solutions. Buffer solutions were prepared by using 
Milli-Q water. As elution buffer two different solvent systems were employed. The first solvent 
system was solvent A2 (20 mM Tris-Cl, pH 8.0) and solvent B2 (20 mM Tris-Cl, 1.25 M NaCl, 
pH 8.0) under denaturating conditions at 80° C with a gradient of B2 from 25% to 60% over 30 
min. The second solvent system was solvent A3 (10 mM NaOH, pH 12) and solvent B3 (10 mM 
NaOH, 1.25 M NaCl, pH 12) under denaturating conditions with a gradient of B3 from 35% to 
70% over 30 min. The fractions containing the desired product were collected and neutralized to 
















6.3 CHARACTERIZATION  
 
Nuclear Magnetic Resonance Spectroscopy (NMR)  
1H-, 13C- and 31P- NMR spectra were recorded on a Varian Unity 300 spectrometer, a Varian 
Inova 500 or 600 or a Bruker 300 or 400 spectrometer. Chemical shifts (δ) were reported in parts 
per million (TMS = ppm). The resonances of the rest protons of deuterated solvents were taken 
as internal standards. CDCl3: 7.24 ppm (1H-NMR) and 77.0 ppm (13C-NMR), DMSO-D6: 2.49 ppm 
(1H-NMR) and 39.5 ppm (13C-NMR).  Abbreviations for signals are: s (singlet), d (doublet), 
t (triplet), q (quartet), m (multiplet), bs (broad singlet). Coupling constants nJX,Y are given in Hertz 
(Hz), where n is the order of coupling. 13C spectra were recorded as broadband decoupled ATP 
spectra. Data from [1H,1H]-COSY, HSQC and HMBC experiments were used to interpret the 
signals. 
 
Mass Spectrometry (MS) 
Electrospray-ionization mass spectras (ESI-MS) were obtained with a Finnigan instrument (type 
LGC or TSQ 7000) or Bruker spectrometers (Apex-Q IV 7T and micrOTOF API). High Resolution 
(HR) spectra were obtained with the Bruker Apex-Q IV 7T or the Bruker micrOTOF, respectively. 
Spectra were provided in the form of relative intensity vs. m/z plots, where m is the total mass 
of the molecule and z is the total charge of the molecule.  
 
Ultraviolet Spectroscopy (UV/Vis) 
Concentrations of oligonucleotides were calculated using UV spectrometer on (i) a JASCO 
V-550 UV/VIS spectrometer (Gross-Umstadt, Germany) (d=1 cm) while the sample cell was 
floated with nitrogen or (ii) with a Thermo Scientific Nanodrop 2000c (d=0.1 cm). Molecular 
absorption coefficients were calculated for the oligonucleotide sequence via summation of the 
monomer nucleobase absorption coefficients at 260 nm. Cytosine: ε260 nm= 7050 L∙mol-1∙cm-1, 









UV-Thermal Melting Analysis 
Melting temperatures of oligonucleotide duplexes were determined on a Jasco V-550 UV/VIS 
system with a peltier heating accessory Jasco ETC-505S/ETC-505T. Measurements were carried 
out in a quartz cuvettes of 1 cm path length. 1:1 mixture of each strand (5 µM) was prepared in 
10 mM phosphate buffer pH 7, 100 mM NaCl (500 µL total volume). The quartz cuvette was 
covered with silicon oil and tightly plugged. The change in absorbance at 260 nm was recorded 
on a range of 4-80 °C with a heating rate of 0.4 °C/min. Detailed experimental conditions are 
stated with the respective experiments.  The value of the Tm was calculated from the first 
derivative of the melting curve and smoothed (Savitzky-Golay). 
  
Circular Dichroism 
CD spectra were recorded on a Jasco-810 spectropolarimeter (Gross-Umstadt, Germany) 
equipped with a Jasco PTC432S temperature controller using the Jasco Spectra Manager control 
(V 1.17.00) and application (V 1.53.00) software package. The sample cell was floated with 
nitrogen. For CD spectra recording of double strand oligonucleotides, buffer conditions are 
stated with the respective experiments. For experiments 1 mm glass cuvette were used. The 
single strand oligonucleotide concentrations were adjusted to 5 μM. The spectra were recorded 
at 20 °C in a wavelength range of 350-190 nm with 1.0 nm bandwidth, using 1.0 s response and a 
scan speed of 50 nm/min. Five spectra were averaged. Spectra were background-corrected 















6.4 OLIGONUCLEOTIDE SYNTHESIS 
 
Oligonucleotides were synthesized on DNA/RNA/LNA Synthesizer (K&A Laborgeräte, 
Schaafheim, Germany) using standard β-cyanoethyl phosphoramidite method.[27] Reagents for 
oligonucleotide syntheses (3% dichloroacetic acid in toluene, 5-benzylmercaptotetrazole, 0.02 M 
Iodine in THF/pyridine) were purchased from EMP BIOTECH (Berlin, Germany). Nucleoside 
phosphoramidite monomers were supplied by Sigma-Aldrich (Taufkirchen, Germany) with base 
labile protecting groups for the natural nucleobases (Ac for dC, Dmf for dG and Bz for dA). The 
Controlled Pore Glass (CPG) solid support attached by a succinimide linker at the 3'- end of 5'-
 protected deoxynucleoside (A, C, T or G) in 200 nmol were supplied by Link Technologies 
(Lanarkshine, UK). Milli-Q water was used in all syntheses and applications for oligonucleotides. 
For oligonucleotide synthesis the nucleoside phosphoramidite building blocks was dissolved in 
dry acetonitrile (1 g nucleoside in 20 mL acetonitrile). Complementary strands were purchased 
from BIOMERS (Ulm/Donau, Germany). 
Desalting of Oligonucleotides In order to prepare oligonucleotides for ESI-MS, RP- and AE-HPLC 
purified oligonucleotides were desalted using Sep-Pak® C18 cartridges (Waters, Milford, USA). 
Initially, the cartridge was washed with 10 mL acetonitrile to wet the stationary phase. 
Conditioning was followed by an equilibration step using 10 mL TEAA buffer (0.1 M, pH 7.0). The 
oligonucleotide was dissolved in 1.5 mL TEAA buffer (0.1 M, pH 7.0) and then loaded very slowly 
onto the cartridge. After loading the sample, the cartridge was washed with Milli-Q water in 
order to remove salts while retaining the oligonucleotide. Elution of the more strongly bound 
oligonucleotide was performed by Milli-Q/acetonitrile (50:50, v/v). 
Oligonucleotides were desalted after dynamic nucleobase incorporation reactions using 
Centri∙Pure N10 gel filtration columns (emp Biotech, Berlin, Germany). Initially, the column was 
equilibrated by loading it with 5 mL Milli-Q water. The oligonucleotide was dissolved in 1.0 mL 
Milli-Q water and then transferred to the column. After the sample was entered to the gel bed 
completely, an Eppendorf cap was placed under the column for the sample collection. Elution of 








6.5 DYNAMIC NUCLEOBASE INCORPORATION  
 
Prior to the reactions, stock solutions of ON1 and template strands were prepared by dissolving 
the strands in the same buffer used for the dynamic exchange reactions (20 mM sodium 
phosphate buffer, 1 M NaCl, pH 6). Stock solutions of the nucleobase aldehydes were prepared 
freshly in the same buffer as for oligonucleotides (20 mM sodium phosphate buffer, 1 M NaCl pH 
6.0). 
 
6.5.1 BASE-FILLING REACTIONS IN THE PRESENCE OF SINGLE NUCLEOBASE  
 
ON1 (50.0 µL of a  200 µM stock solution, 10.0 nmol, 1.0 eq.), template strand (50.0 µL of a  
200 µM stock solution, 10.0 nmol, 1.0 eq.), one of the four aldehyde-nucleobases (40.0 µL of a 7 
mM stock solution, 280 nmol, 28 eq.) and buffer (120 µL of 20 mM phosphate buffer, pH 6, 1 M 
NaCl) were mixed in an Eppendorf cap and incubated at room temperature for three hours. For 
reduction NaBH3CN (50.0 µL of 1 M stock solution, 50.0 µmol) was added and shaking continued 
for one hour. The reaction mixture was passed through a gel filtration column (Centri∙Pure N10) 
to remove excess of aldehydes and salts. After lyophilization of the samples, crude products 
were analyzed by AE-HPLC using solvent system A2 and B2 at 80 °C.  
 
6.5.2 BASE-FILLING REACTIONS IN THE PRESENCE OF FOUR NUCLEOBASES AT EQUIMOLAR 
CONCENTRATIONS 
 
ON1 (50.0 µL of a  200 µM stock solution, 10.0 nmol, 1.0 eq.), template strand (50.0 µL of a  200 
µM stock solution, 10.0 nmol, 1.0 eq.), aldehyde-nucleobases GCHO, CCHO, ACHO, TCHO (each in 40 
µL of a 7 mM stock solution, 280 nmol, 28 eq.) were mixed and incubated at room temperature 
for three hours. For reduction NaBH3CN (50 µL of 1 M stock solution, eq.) was added and shaking 
continued for one hour. The reaction mixture was purified by gel filtration (Centri∙Pure N10 
columns) to remove excess of aldehydes and salts. After lyophilization of the samples, crude 
products were analyzed using AE-HPLC under two different conditions: Solvent system A2 and 







6.5.3 BASE-FILLING REACTIONS IN THE PRESENCE OF FOUR NUCLEOBASES AT NON-EQUIMOLAR 
CONCENTRATIONS 
 
Reactions were performed similarly as described in 5.5.2, with the following amounts of 
aldehydes: GCHO (40.0 µL of a 7 mM stock solution, 280 nmol, 28 eq.), CCHO (40.0 µL of a 9 mM 
stock solution, 364 nmol, 36 eq.), ACHO (40.0 µL of a 13 mM stock solution, 504 nmol, 50 eq.), 
TCHO (40.0 µL of a 23 mM stock solution, 924 nmol, 92 eq.). 
 
6.5.4 TEST OF REVERSIBILITY 
 
ON1 (50.0 µL of a  200 µM stock solution, 10.0 nmol, 1.0 eq.), template strand (50.0 µL of a  200 
µM stock solution, 10.0 nmol, 1.0 eq.), aldehyde-nucleobases CCHO, ACHO, TCHO (each in 40 µL of a 
7 mM stock solution, 280 nmol, 28 eq.) were mixed and incubated at room temperature. After 
three hours GCHO was added and incubated for further one hour. For reduction NaBH3CN (50 µL 
of 1 M stock solution, eq.) was added and shaking continued for one hour. The reaction mixture 
was purified by gel filtration (Centri∙Pure N10 columns) to remove excess of aldehydes and salts. 
After lyophilization of the samples, crude products were analyzed using AE-HPLC under two 
different conditions: Solvent system A2 and B2, 80 °C or solvent system A3 and B3, pH 12. 
 
6.5.5 PHENANTROLINE INCORPORATION WITH ABASIC TEMPLATE 
 
ON1 (50.0 µL of a  200 µM stock solution, 10.0 nmol, 1.0 eq.), template strand (50.0 µL of a  200 
µM stock solution, 10.0 nmol, 1.0 eq.), P2CHO and aldehyde-nucleobases GCHO, CCHO, ACHO, TCHO 
(each in 40 µL of a 7 mM stock solution, 280 nmol, 28 eq.) were mixed and incubated at room 
temperature for three hours. For reduction NaCNBH3 (50 µL, 1 M) was added and shaking 
continued for one hours. The reaction mixture was purified by gel filtration (Centri∙Pure N10 
columns) to remove excess of aldehydes and salts. After lyophilization of the samples, crude 










6.6 SYNTHESIS OF D-THREONINOL-BASED PHOSPHORAMIDITE MONOMER 
 












D-Threoninol (1) (500 mg, 4.76 mmol, 1.00 eq.) was added to a stirring suspension of 
N-[[(fluoren-9-ylmethoxy)-carbonyl]oxy]-succinimide (Fmoc-OSu) (500 mg, 4.76 mmol, 1.00 eq.) 
in a mixture of aceton/water (1:1 v/v, 20 mL) containing sodium hydrogen carbonate (1.67 g, 
4.76 mmol, 1.00 eq.). The reaction mixture was stirred overnight at room temperature. After 
removal of the solvent under reduced pressure, the crude product was taken up in 
dichloromethane (50 mL), washed with water (2 x 50 mL), dried over sodium sulfate, filtered and 
concentrated under reduced pressure. Purification by flash column chromatography 
(dichloromethane/methanol, 9:1) afforded 2 as a white solid (1.40 g, 4.28 mmol, 90%). 
TLC Rf = 0.52 (dichloromethane/methanol, 9:1). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.18 (d, 3H, 3JH,H = 6.3 Hz, H-4), 2.47 (s, 2H, 2 x OH), 
3.48-3.59 (m, 1H, H-2), 3.78 (d, 2H, 3JH,H = 3.7 Hz, H-1), 4.08-4.15 (m, 1H, H-3), 4.17 (t, 1H, 3JH,H = 
6.6 Hz, Fmoc-CH), 4.35-4.50 (m, 2H, Fmoc-CH2), 5.49 (d, 1H,  3JH,H = 8.3 Hz, NH), 7.25-7.32 (m, 2H, 
Fmoc-2,7-H), 7.33-7.40 (m, 2H, Fmoc-3,6-H), 7.58 (d,  2H, 3JH,H= 7.3 Hz, Fmoc-1,8-H), 7.74 (d, 
2H, 3JH,H= 7.4 Hz, Fmoc-4,5-H). 
13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 20.35 (1C, C-4), 47.27 (1C, Fmoc-CH), 55.98 (1C, C-3), 
64.99 (1C, C-1), 66.72 (1C, Fmoc-CH2), 68.85 (1C, C-2), 119.95 (2C, Fmoc-1,8-C), 125.00 (2C, 
Fmoc-2,7-C), 127.02 (2C, Fmoc-4,5-C), 127.69 (2C, Fmoc-3,6-C), 141.32 (2C, Fmoc-11,12-C), 
143.81 (2C, Fmoc-1,8-C), 156.99 (1C, Fmoc-CO). 
ESI-MS: m/z (rel.%) = 350.1 (26) [M+Na]+, 677.3 (100) [2M+Na]+.  
















C40H39NO6 [629.75]  
Prior to the reaction, Fmoc-D-threoninol (2) (500 mg, 1.53 mmol, 1.00 eq.) was dried by 
coevaporation with dry pyridine (3 x 15 mL) and then dissolved in dry pyridine (15 mL) under 
argon. 4,4'-Dimethoxytritylchloride (569 mg, 1.68 mmol, 1.10 eq.), 4-(dimethylamino)-pyridine 
(DMAP) (9.35 mg, 0.08 mmol, 0.05 eq.) and triethylamine (0.3 mL, 2.14 mmol, 1.40 eq.) was 
added to this solution and was stirred at room temperature overnight. Pyridine was evaporated 
under reduced pressure and the crude product was taken up in dichloromethane and washed 
with water (3 x 50 mL). The organic phase was further washed with saturated sodium 
hydrogencarbonate solution (30 mL) and water (30 mL). The organic phase was dried over 
sodium sulfate, filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (dichloromethane/methanol/triethylamine, 99:1:0.5) afforded 3 as a yellow oil 
(787 mg, 1.25 mmol, 82%). 
 
TLC Rf = 0.63 (dichloromethane/methanol/triethylamine, 99:1:0.5). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.16 (d, 3H, 3JH,H = 6.3 Hz, H-4), 2.92 (s, 1H, OH), 
3.20-3.41 (m, 2H, H-1), 3.64-3.71 (m, 1H, H-2), 3.73 (s, 6H, -OCH3), 4.04-4.13 (m, 1H, H-3), 4.23 
(t, 1H, 3JH,H = 7 Hz, Fmoc-CH), 4.30-4.47 (m, 2H, Fmoc-CH2), 5.47 (d, 1H,  3JH,H = 8.3 Hz, NH), 6.76-
6.84 (m, 4H, DMT-H), 7.18- 7.32 (m, 9H, DMT-H), 7.35-7.40 (m, 4H, Fmoc-2,7-H, Fmoc-3,6-H), 
7.59-7.69 (m, 2H, Fmoc-1,8-H), 7.74-7.77 (m, 2H, Fmoc-4,5-H). 
13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 20.14 (1C, C-4), 47.64 (1C, Fmoc-CH), 55.47 (2C, 
2 x -OCH3), 55.99 (1C, C-3), 64.97 (1C, C-1), 67.01 (1C, Fmoc-CH2), 67.97 (1C, C-2), 86.79 (1C, 
DMT-C), 113.47 (4C, DMT-C), 120.21 (2C, Fmoc-1,8-C), 123.98 (2C, Fmoc-2,7-C), 125.38 (3C, 




(2C, DMT-C), 130.24 (2C, DMT-C), 141.57 (2C, Fmoc-11,12-C), 144.41 (2C, Fmoc-10,13-C), 144.43 
(1C, DMT-C), 150.06 (1C, Fmoc-CO), 159.00 (2C, DMT-C). 
ESI-MS: m/z (rel.%) = 652.3 (100) [M+Na]+, 1281.5 (33) [2M+Na]+. 























































Prior to the reaction DMT-Fmoc-D-threoninol (3) (500 mg, 0.79 mmol, 1.00 eq.) was dried by 
coevaporation with dry pyridine (3 x 15 mL) and then dissolved in dry dichloromethane (15 mL) 
uder argon. N,N-Diisopropylethylamine (DIPEA) (0.20 mL, 1.20 mmol, 1.50 eq.) and 
2-cyanoethyl-N,N-diisopropylphosphoramiditchloride (0.24 mL, 1.03 mmol, 1.30 eq.) was added 
at 0 °C dropwise while stirring. The reaction mixture was stirred for three hours at room 
temperature under argon and washed with addition of saturated sodium hydrogencarbonate 
solution (10 mL). The water phase was further washed with dichloromethane (3 x 10 mL). The 
combined organic phase was dried over sodium sulfate and the solvent was removed under 
reduced pressure. The crude product was subjected to column chromatography 
(n-pentane/ethyl acetate, 3:1). The desired fractions were collected and evaporated under 
reduced pressure. The purified product was dissolved in chloroform (1 mL) and precipitated in 
cold hexane at 0 °C (50 mL). The product was filtered, washed with cold hexane and dried under 
high vacuum to afford 4 as a white powder (268 mg, 0.33 mmol, 43%). 
 
TLC Rf = 0.38 (n-Pentane/ethyl acetate, 3:1). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.09-1.19 (m, 12H, 2 x -CH(CH3)2), 1.23 (d, 3H, 3JH,H = 
6.4 Hz, H-4), 2.36 (t, 2H, 3JH,H = 6.3 Hz, -CH2CN), 3.15-3.23 (m, 2H, 2 x -CH(CH3)2), 3.40-3.59 (m, 
4H, H-1, -OCH2CH2CN), 3.76 (s, 6H, 2 x -OCH3), 3.83-3.93 (m, 1H, H-2), 4.18-4.27 (m, 1H, H-3), 
4.27-4.37 (m, 1H, Fmoc-CH), 4.37-4.44 (m, 2H, Fmoc-CH2), 5.08 (d, 1H, 3JH,H = 8.3 Hz, NH), 6.73-
6.86 (m, 4H, DMT-H), 7.14-7.45 (m, 13H, Fmoc-2,7-H, Fmoc-3,6-H, DMT-H), 7.55-7.64 (m, 2H, 




13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 19.42 (1C, C-4), 20.10 (1C, -CH2CN), 24.58 (4C, 
2 x -CH(CH3)2), 43.06 (1C, Fmoc-CH), 47.28 (2C, 2 x -CH(CH3)2), 55.15 (2C, 2 x -OCH3), 56.23 (1C, 
C-3), 58.17 (1C, -OCH2CH2CN), 63.02 (1C, C-1), 66.61 (1C, Fmoc-CH2), 68.89 (1C, C-2), 86.05 (1C, 
DMT-CH), 113.01 (4C, DMT-CHAr), 117.59 (1C, CN), 119.89 (2C, Fmoc-1,8-C), 125.02 (2C, Fmoc-
2,7-C), 126.98 (3C, Fmoc-4,5-C, DMT-C), 127.60 (2C, Fmoc-3,6-C), 127.74 (4C, DMT-C), 128.22 
(2C, DMT-C), 130.05 (2C, DMT-C), 135.97 (2C, DMT-C), 141.24 (2C, Fmoc-11,12-C), 143.90 (2C, 
Fmoc-10,13-C), 144.75 (1C, DMT-C), 156.35 (1C, Fmoc-CO), 158.42 (2C, DMT-C). 
31P-NMR (121 MHz, CDCl3, RT): δ (ppm) = 148.  
ESI-MS: m/z (rel.%) = 830.4 (18) [M+H]+, 852.4 (100) [M+Na]+.  
HRMS (ESI): calcd. for [C49H57N3O6P] ([M+H]+): 830.3929, found: 830.3929, calcd. for 





















6.7 SYNTHESIS OF NUCLEOBASE-ALDEHYDES  















A suspension of 2-amino-6-chloropurine (6.00 g, 35.4 mmol, 1.00 eq.), cesium carbonate (5.80 g, 
17.7 mmol, 0.50 eq.) and bromoacetaldehyde diethyl acetal (8.20 mL, 53.1 mmol, 1.50 eq.) in 
dry N,N'-dimethylformamide (150 mL) was heated at 100 °C under stirring for 24 h. The reaction 
mixture was filtered when it is hot through celite and concentrated under reduced pressure. The 
residue was taken up in water (100 mL) and extracted with boiling chloroform (3 x 150 mL), 
filtered through celite and evaporated under reduced pressure. Before column chromatography 
the residue was taken up in methanol (150 mL) and was treated with silica gel and evaporated. 
Purification by flash column chromatography (dichloromethane/methanol, 95:5) afforded 6 as a 
white solid (6.00 g, 21.2 mmol, 60%). 
 
TLC Rf = 0.35 (dichloromethane/methanol, 95:5). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.18 (t, 6H, 3JH,H =7.1 Hz, 2 x CH3), 3.49 (dq, 
2H, 2JH,H = 9.2 Hz, 3JH,H = 7.1 Hz, -OCH2CH3), 3.72 (dq, 2H, 2JH,H = 9.2 Hz, 3JH,H = 7.1 Hz, -OCH2CH3), 
4.17 (d, 2H, 3JH,H = 5.2 Hz, NCH2), 4.67 (t, 1H, 3JH,H = 5.2 Hz, CH(OEt)2), 5.10 (s, 2H, NH2), 7.85 (s, 
1H, H-8).  
13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 15.08 (2C, 2 x CH3), 46.03 (1C, NCH2), 63.65 (2C, 
2 x OCH2CH3), 99.93 (1C, CH(OEt)2), 124.66 (1C, C-5), 143.35 (1C, C-8), 150.96 (1C, C-6), 153.88 
(1C, C-4), 159.16 (1C, C-2).  
ESI-MS: m/z (rel.%): 286.1 (100) [M+H]+, 308.1 (18) [M+Na]+, 571.2 (17) [2M+H]+, 593.2 (53) 
[2M+Na]+.  
HRMS (ESI): calcd. for [C11H17ClN5O2]+ ([M+H]+): 286.1065, found: 286.1071; calcd. for 



















2-Amino-6-chloro-9-(2,2-diethoxyethyl)-purine (10.0 mg, 35.0 mmol) was dissolved in TFA/H2O 
(1:2 v/v, 0.50 mL) and heated at 100 °C in the microwave for 30 min. After removal of TFA, it was 
lyophilized to give 2-(guanin-9-yl)-ethanal hydrate trifluoroacetate (9) as a blue solid (7 mg, 
35 mmol, 90%). 
TLC Rf = 0.07 (dichloromethane/methanol, 90:10). 
1H-NMR (300 MHz, D2O, RT): δ (ppm) = 4.35 (d, 2H, 3JH,H=4.7 Hz, NCH2), 5.47 (t, 1H, 3JH,H=4.7 Hz, 
CH(OH)2), 8.78 (s, 1H, H-8).  
13C-NMR (126 MHz, D2O, RT): δ (ppm) = 52.10 (1C, NCH2), 89.39 (1C, (CHOH)2), 111.08 (1C, C-5), 
120.11 (1C, CF3), 141.11 (1 C, C-8), 153.13 (1C, C-4), 157.79 (1C, C-2), 158.35 (1C, C-6), 165.34 
(1C, COCF3)  
ESI-MS: m/z (rel.%): 194.07 (72) [M+H]+, 212.08 (100) [M+H3O]+. 





















C11H17N5O2 [251.29]  
 
A mixture of adenine (1.00 g, 7.40 mmol, 1.00 eq.), dry potassium carbonate (1.00 g, 7.4 mmol, 
1.00 eq.) and bromoacetaldehyde diethyl acetal (1.10 mL, 7.40 mmol, 1.00 eq.) in dry 
N,N'-dimethylformamide (20 mL) was heated at 110 °C under stirring for 24 h. The reaction 
mixture was concentrated under reduced pressure. The residue was taken up in water (30 mL) 
and extracted with ethyl acetate (3 x 50 mL). The combined organic phase was washed with 
brine and dried over sodium sulfate. Purification by flash column chromatography 
(dichloromethane/methanol, 90:10) afforded 11 as a white solid (1.10 g, 4.44 mmol, 60%). 
 
TLC Rf = 0.50 (dichloromethane/methanol, 90:10). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.14 (t, 6H, 3JH,H = 7 Hz, 2 x CH3), 3.47 (dq, 
2H, 2JH,H = 9.5 Hz, 3JH,H = 7 Hz, OCH2CH3), 3.72 (dq, 2H, 2JH,H = 9.5 Hz, 3JH,H = 7 Hz, OCH2CH3), 4.26 
(d, 2H, 3JH,H = 5.5 Hz, NCH2), 4.70 (t, 1H, 3JH,H = 5.5 Hz, CH(OEt)2), 5.96 (s, 2H, NH2), 7.89 (s, 1H, H-
2 ), 8.33 (s, 1H, H-8). 
13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 15.18 (2C, 2 x CH3), 46.27 (1C, NCH2), 63.91 (1C, 
OCH2CH3), 100.31 (1C, CH(OEt)2), 119.17 (1C, C-5), 141.81 (1C, C-8), 150.19 (1C, C-4), 152.54 
(1C, C-2), 155.21 (1C, C-6). 
ESI-MS: m/z (rel. %): 252.2 (100) [M+H]+. 
HRMS (ESI): calcd. for [C11H18N5O2]+ ([M+H]+): 252.1455, found: 252.1455; calcd. for 

























9-(2,2-Diethoxyethyl)-adenine (10.0 mg, 40.0 mmol) was dissolved in TFA/H2O (1:1 v/v, 0.50 mL) 
and heated at 100 °C in the microwave for 30 min. After removal of TFA it was lyophilized to give 
12 as a white solid (7 mg, 40.0 mmol, quantitative). 
 
TLC Rf = 0.50 (dichloromethane/methanol, 90:10). 
1H-NMR (300 MHz, D2O, RT): δ (ppm) = 4.45 (d, 2H, 3JH,H = 4.7 Hz, NCH2), 5.47 (t, 
1H, 3JH,H = 4.7 Hz, CH(OH)2), 8.40 (s, 1H, H-2), 8.47 (s, 1H, H-8).  
13C-NMR (126 MHz, D2O, RT): δ (ppm) = 51.84 (1C, NCH2), 90.02 (1C, (CH(OH)2), 117.78 (1C, 
CF3), 120.10 (1C, C-5), 147.02 (1C, C-8), 148.05 (1C, C-4), 151.52 (1C, C-2), 152.50 (1C, C-6), 
165.31 (1C, COCF3). 
ESI-MS: m/z (rel. %): 178.1 (9) (M+H)+, 210.1 (100) (M+Na)+. 
HRMS (ESI): calcd. for aldehyde [C7H8N5O]+ ([M+H]+): 178.0723, found: 178.0725; calcd. for 


























A suspension of cytosine (1.00 g, 9.00 mmol) in acetic anhydride (10 mL) and glacial acetic acid 
(2 mL) was refluxed overnight under nitrogen. The reaction mixture was cooled down to room 
temperature and the insoluble product was filtered and collected. It was washed with cold 
ethanol (10 mL), followed by diethyl ether (10 mL) and dried to afford derivative 14 as a white 
solid (1.20 g, 8.00 mmol, 88%). 
 
TLC Rf = 0.35 (dichloromethane/methanol, 90:10). 
1H NMR (300 MHz, CDCl3, RT): δ (ppm) = 2.08 (s, 3H, CH3), 7.07 (d, 1H, 3JH,H = 7 Hz, H-5), 7.78 (d, 
1H, 3JH,H = 7 Hz, H-6), 13.30 (s, 1H, H-1).  
13C NMR (126 MHz, CDCl3, RT): δ (ppm) = 24.25 (1C, CH3), 94.34 (1C, C-5), 146.90 (1C, C-6), 
155.93 (1C, C-2), 162.95 (1C, C-4), 170.56 (1C, COCH3). 
ESI-MS: m/z (rel.%): 154.1 (25) [M+H]+, 176.1 (100) [M+Na]+.  
HRMS (ESI): calcd. for [C6H8N3O2]+ ([M+H]+): 154.0611, found: 154.0612; calcd. for 



























A mixture of 4-N-acetylcytosine (3.60 g, 23.4 mmol, 1.00 eq.), dry potassium carbonate (3.32 g, 
23.4 mmol, 1.00 eq.) and bromoacetaldehyde diethyl acetal (3.8 mL, 23.4 mmol, 1.00 eq.) in dry 
N,N'-dimethylformamide (60 mL) was heated at 130 °C under stirring for 24 h. The resulting dark 
brown reaction mixture was filtered when it is hot through celite and concentrated under 
reduced pressure. The residue was taken up in water (100 mL) and extracted with ethyl acetate 
(3 x 150 mL). The combined organic phase was washed with brine (100 mL), dried over sodium 
sulfate, filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (dichloromethane/methanol, 95:5) afforded derivative 15 as a yellow solid 
(3.80 g, 14.0 mmol, 60%). 
 
TLC Rf = 0.50 (dichloromethane/methanol, 95:5). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.24 (t, 6H, 3JH,H = 7 Hz, 2 x -OCH2CH3), 2.03 (s, 3H, 
COCH3), 3.42 (dq, 2H, 2JH,H = 9 Hz, 3JH,H = 7 Hz, OCH2CH3), 3.62 (dq, 2 H, 2JH,H = 9 Hz, 3JH,H = 7 Hz, -
OCH2CH3), 3.80 (d, 2H, 3JH,H = 5.5 Hz, NCH2), 4.72 (t, 1H, 3JH,H = 5.5 Hz, CH(OEt)2), 7.12 (d, 1H, 
3JH,H = 7 Hz, H-5), 7.68 (d, 1H, 3JH,H = 7 Hz, H-6), 10.78 (s, 1H, NH). 
13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 15.63 (2C, 2 x CH3), 54.1 (1C, NCH2), 64.71 
(1C, -OCH2CH3), 97.23 (1C, C-5), 100.8 (1C, CH(OEt)2), 152.4 (1 C, C-6), 158.16 (1C, C-2), 164.11 
(1C, C-4), 172.8 (1C, CO). 
ESI-MS: m/z (rel.%): 270.2 (100) [M+H]+. 
HRMS (ESI): calcd. for [C12H20N3O4]+ ([M+H]+): 270.1448, found: 270.1450; calcd. for 
















C10H17N3O3 [227.26]  
 
 A solution of 4-N-acetyl-1-(2,2-diethoxyethyl)-cytosine 8 (0.50 g, 1.8 mmol) in methanolic 
ammonia (2 M, 10 mL) was stirred at room temperature for 92 h. The reaction mixture was 
concentrated under reduced pressure to a white solid. Purification by column chromatography 
(dichloromethane/methanol, 95:5) afforded derivative 16 as a white product (0.296 g, 
1.26 mmol, 70%). 
 
TLC Rf = 0.20 (dichloromethane/methanol, 90:10). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.15 (t, 6H, 3JH,H = 7 Hz, 2 x -OCH2CH3), 3.52 (dq, 
2H, 2JH,H = 9.5 Hz, 3JH,H = 7 Hz, -OCH2CH3), 3.72 (dq, 2H, 2JH,H = 9.5 Hz, 3JH,H = 7 Hz, -OCH2CH3), 
3.80 (d, 2H, 3JH,H = 5.4 Hz, NCH2), 4.72 (t, 1H, 3JH,H = 5.4 Hz, CH(OEt)2), 5.81 (d, 1H, 3JH,H = 7.2 Hz, 
H-5), 7.48 (d, 1H, 3JH,H = 7.2 Hz, H-6).  
13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 15.63 (2C, 2 x CH3), 53.52 (1C, NCH2), 64.91 
(1C, -OCH2CH3), 95.23 (1C, C-5), 101.47 (1C, CH(OEt)2), 148.75 (1C, C-6), 159.16 (1C, C-2), 168.11 
(1C, C-4). 
ESI-MS: m/z (rel.%): 228.1 (100) [M+H]+, 455.3 (82) [M+Na]+.  
HRMS (ESI): calcd. for [C10H18N3O3]+ ([M+H]+): 228.1343, found: 228.1346; calcd. for 























1-(2,2-Diethoxyethyl)cytosine (16) (20.0 mg, 0.08 mmol) was dissolved in TFA/H2O (1:1 v/v, 
1.00 mL) and was heated at 100 °C in the microwave for 30 min. After removal of TFA it was 
lyophilized to give yellow oil. Purification by flash column chromatography 
(dichloromethane/methanol, 75:25) afforded derivative 10 as a white solid (10.7 mg, 0.07 mmol, 
90%). 
 
TLC Rf = 0.45 (dichloromethane/methanol, 75:25). 
1H NMR (300 MHz, D2O, RT): δ (ppm) = 3.97 (d, 2H, 3JH,H = 5.1 Hz, CH2), 5.34 (t, 1H, 3JH,H = 5.1 Hz, 
CH(OH)2), 6.22 (d, 1H, 3JH,H = 7.7 Hz, H-5), 7.87 (d, 1H; 3JH,H = 7.7 Hz, H-6). 
13C NMR (126 MHz, D2O, RT): δ (ppm) = 53.31 (1C, NCH2), 88.40 (1C, (CH(OH)2), 95.20 (1C, C-5), 
116.58 (1C, CF3),  148.30 (1C,  C-6),  159.9 (1C, C-2), 165.34 (1C, COCF3), 168.34 (1C, C-4). 
ESI-MS: m/z (rel. %): 154.1 (100) [M+H]+, 172.1 (25) [M+H3O]+. 






















C11H18N2O4  [242.28]  
 
A mixture of thymine (1.00 g, 8.10 mmol, 1.00 eq.), dry potassium carbonate (1.10 g, 8.1 mmol) 
and bromoacetaldehyde diethyl acetal (1.22 mL, 8.1 mmol, 1.00 eq.) in dry 
N,N'-dimethylformamide was heated at 110 °C under stirring for 24 h. The reaction mixture was 
concentrated under reduced pressure. The residue was taken up in water (30 mL) and extracted 
with ethyl acetate (3 x 50 mL). Purification by column chromatography 
(dichloromethane/methanol, 95:5) afforded derivative 19 as a yellow product (0.78 g, 3.24 
mmol, 55%). 
 
TLC Rf = 0.30 (dichloromethane/methanol, 95:5). 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 1.11 (t, 6H, 3JH,H = 7.2 Hz, 2 x CH3), 1.83 (d, 
3H, 3JH,H = 1.2 Hz, C=CCH3), 3.46 (dq, 2H, 2JH,H = 9.6 Hz, 3JH,H = 7.2 Hz, -OCH2CH3), 3.68 (dq, 2H, 
2JH,H = 9.6 Hz, 3JH,H = 7.2 Hz, -OCH2CH3), 4.56 (t, 1H, 3JH,H = 5.4 Hz, CH(OEt)2), 7.04 (q, 
1H, 3JH,H = 1.2 Hz, C=CH), 10.04 (bs, 1H, NH). 
13C NMR (126 MHz, CDCl3, RT): δ (ppm) = 12.72 (1C, C=CH3), 15.10 (2C, 2 x CH3), 50.66 (1C, 
NCH2), 64.08 (2C, 2 x OCH2CH3), 100.20 (1C, CH(OEt)2), 109.72(1C, C=CH3), 141.95 (1C, C-6), 
151.30 (1C, C-2), 164.68 (1C, C-4).  
ESI-MS: m/z (rel. %): 243.1 (62) [M+H]+, 265.1 (100) [M+Na]+. 
HRMS (ESI): calcd. for [C11H19N2O4]+ ([M+H]+): 243.1339, found: 243.1339; calcd. for 
























1-(2,2-Diethoxyethyl)-thymine (10.0 mg, 0.04 mmol) was dissolved in TFA/H2O (1:1 v/v, 0.5 mL) 
and heated at 100 °C in the microwave for 30 min. After removal of TFA it was lyophilized to give 
14 (6.73 mg, 0.04 mmol, 90%) as a yellow solid. 
 
TLC Rf = 0.30 (dichloromethane/methanol, 95:5). 
1H-NMR (300 MHz, D2O, RT): δ (ppm) = 1.91 (s, 3H, CH3), 3.86 (d, 2H, 3JH,H = 5.2 Hz, CH2), 5.30 (t, 
1H, 3JH,H = 5.2 Hz, CH(OH)2), 7.49 (s, 1H, C=CH).  
13C-NMR (126 MHz, D2O, RT): δ (ppm) = 13.81 (1C, C=CH3), 55.71 (1C, NCH2), 89.98 (1C, 
CH(OEt)2), 112.99 (1C, C-5), 146.38 (1C, C-6), 155.02 (1C, C-2), 169.53 (1C, C-4). 
ESI-MS: m/z (rel.%): 169.1 (100) [M+H]+. 
HRMS (ESI): calcd. for aldehyde [C7H9N2O3]+ ([M+H]+): 169.0608, found: 169.0609; calcd. for 

















6.8 SYNTHESIS OF PHENANTROLINE-ALDEHYDES 






C14H12N2O [224.26]  
 
A stirred solution of 2,9-dimethyl-1,10-phenantroline (1.00 g, 4.8 mmol) in glacial acetic acid (6 
mL) and heated to 60 °C under reflux. Then hydrogen peroxide (0.93 mL, 30%) was added and 
heated further 3 hours under reflux. The reaction mixture was cooled down at room 
temperature. The mixture was added to sodium carbonate solution in order to bring the pH in 
neutral range. The resulting mixture was extracted with dichloromethane, dried over 
magnesium sulfate and evaporated under reduced pressure to afford derivative 22 as a black 
solid (1.06 g, 4.75 mmol, 99%). 
 
1H NMR (300 MHz, CDCl3, RT): δ (ppm) = 2.74 (s, 3H, 2-phenCH3), 2.89 (s, 3H, 9-phenCH3), 7.46 
(d, 1H, 3JH,H = 8.1 Hz, H-3), 7.48 (d, 1 H, 3JH,H = 8.1 Hz, H-8), 7.59-7.63 (m, 2H, H-5, H-6), 7.67 (d, 
1H, 3JH,H = 8.1 Hz, H-4), 8.07 (d, 1H, 3JH,H = 8.2 Hz, H-7).  
13C NMR (126 MHz, CDCl3, RT): δ (ppm) = 19.55 (1 C, 2C-CH3), 26.11 (1 C, 2C-CH3), 123.31 (2 C, 
C5, C6), 123.35 (1C, C8), 123.86 (1C, C3), 125.43 (1C, C4b), 127.83 (1C, C4), 131.69 (1C, C4a), 
135.77 (1C, C7), 136.09 (1C, C10a), 142.20 (1C, C10b), 150.13 (1C, C2), 158.60 (1C, C9).  
ESI-MS: m/z (rel.%): 225.1 (100) (M+H)+, 447.2 (30) (2M-H)-.  
HRMS (ESI): calcd. for [C14H13N2O]+ ([M+H]+): 225.1022, found: 225.1026; calcd. for 

















 C16H14N2O2 [266.30]  
 
To a solution of 2,9-dimethyl-1,10-phenantroline N-Oxide dihydrate (0.50 g, 2.2 mmol) in 
dichloromethane, acetic anhydride (2 mL) was added. Dichloromethane was removed under 
reduced pressure and the solution was refluxed for 1 hour. The solvent was removed under 
reduced pressure and the residue was taken in chloroform, washed with saturated aqueous 
sodium carbonate Na2CO3, dried over magnesium sulfate and again concentrated under 
reduced pressure. The crude residue was eluted through a short Al2O3 column with 
dichloromethane/ethylacetate to afford the derivative 23 (0.53 g, 2.00 mmol, 90%). 
 
1H NMR (300 MHz, CDCl3, RT): δ (ppm) = 2.22 (s, 3H, CO2CH3), 2.97 (s, 3H, 9-phenCH3), 5.66 (s, 
2H, CH2) 7.52 (d, 1H, 3JH,H = 8.1 Hz, H-3), 7.54 (d, 1 H, 3JH,H = 8.1 Hz, H-8), 7.69-7.74 (m, 2H, H-5, 
H-6), 7.77 (d, 1H, 3JH,H = 8.1 Hz, H-4), 8.28 (d, 1H, 3JH,H = 8.2 Hz, H-7). 
13C NMR (126 MHz, CDCl3, RT): δ (ppm) =  20.95 (1 C, COCH3), 25.70 (1C, CH3), 67.7 (1C, CH2), 
120.86 (1C, C8), 123.4 (1C, C3), 123.7 (1C, 6C), 125.2 (1C, 5C), 126.4 (1C, C4b) 127.9 (1C, C4a), 
136.1 (1C, C4), 136.9 (1C, C7), 145.0, (1C, C10a), 145.1 (1C, C10b), 156.3 (1C, C2), 159.5 (1C,C9) 
170.6 (1C, CO). 
ESI-MS: m/z (rel.%): 267.1 (100) (M+H)+, 289.1 (12) (M+Na)+. 
HRMS (ESI): calcd. for [C16H15N2O2]+ ([M+H]+): 267.1128, found: 267.1132; calcd. for 


















 C14H12N2O [224.26]  
 
A suspension of 2-(Acetoxymethyl)-9-methyl-1,10-phenantroline (0.65 g, 2.44 mmol) and 
anhydrous K2CO3 (600 mg) in anhydrous ethanol (15 mL) was stirred for 4 hours. The mixture 
was concentrated under reduced pressure and the residue was extracted with dichloromethane. 
The organic layer was evaporated under reduced pressure to afford the derivative 24 (0.47 g, 
2.12 mmol, 87%).  
 
1H NMR (300 MHz, DMSO, RT): δ (ppm) = 2.93 (s, 3H, 9-phenCH3), 5.11 (s, 2H, CH2), 7.49 (d, 
1H, 3JH,H = 8.1 Hz, H-3), 7.51 (d, 1 H, 3JH,H = 8.1 Hz, H-8), 7.62 (d, 1H, 3JH,H = 8.1 Hz, H-4), 7.71 (d, 
2H, 3JH,H = 8.4 Hz, H-5, H-6), 8.21 (d, 1H, 3JH,H = 8.2 Hz, H-7). 
13C NMR (126 MHz, DMSO, RT): δ (ppm) =  24.93 (1C, CH3), 64.82 (1C, CH2), 119.93 (1C, C3), 
123.06 (1C, C8), 125.20 (1C, 6C), 125.28 (1C, 5C), 125.56 (1C, C4b), 126.33 (1C, C4a), 136.04 (1C, 
C7), 136.09 (1C, C4), 144.48 (1C, C10a), 144.53 (1C,C10b), 157.87 (1C, C9), 161.76 (1C, C2). 
ESI-MS: m/z (rel.%): 225.1 (100) (M+H)+, 247.1 (23) (M+Na)+, 471.2 (43) (2M+Na)+. 
HRMS (ESI): calcd. for [C14H13N2O]+ ([M+H]+): 225.1022, found:225.1022; calcd. for 

























A solution of oxalyl chloride (0.6 mL, 2.33 mmol, 1.60 eq.) in dry dichloromethane (0.2 mL) under 
argon was cooled to -78 °C. A mixture of DMSO (0.18 mL, 2.33 mmol) in dichloromethane (1.50 
mL) was slowly added and it was stirred further 15 minutes at -78 °C. 2-(Hydroxymethyl)-9-
methyl-1,10-phenantroline (0.34 g, 1.5 mmol, 1.00 eq.) in dichloromethane (3 mL) was slowly 
added to this mixture and was stirred for 30 minutes. Triethylamine (1.8 mL) was added to that 
mixture. After the addition was completed, the reaction mixture was warmed up to room 
temperature and 30 minutes later water (20 mL) was added. The organic phase was separated 
and the water phase was extracted with dichloromethane. The combined organic phases were 
washed with brine, dried with magnesium sulfate and concentrated.  Purification by column 
chromatography (dichloromethane/methanol, 98:2) afforded 25 as a yellow solid (0.07 g, 0.3 
mmol, 20%). 
 
1H NMR (300 MHz, DMSO, RT): δ (ppm) = 2.82 (s, 3H, 9-phenCH3), 7.71 (d, 1H, 3JH,H = 8.1 Hz, H-
3), 7.73 (d, 1H, 3JH,H = 8.1 Hz, H-8), 8.08 (d, 2H, 3JH,H = 8.4 Hz, H-5, H-6), 8.22 (d, 1H, 3JH,H = 8.1 Hz, 
H-4), 8.69 (d, 1H, 3JH,H = 8.2 Hz, H-7), 10.12 (s, 1H, CHO) . 
13C NMR (126 MHz, DMSO, RT): δ (ppm) =  25.03 (1C, CH3), 120.74 (1C, C3), 129.76 (1C, C8), 
131.20 (1C, 6C), 131.98 (1C, 5C), 132.56 (1C, C4b), 133.33 (1C, C4a), 143.04 (1C, C7), 143.09 (1C, 
C4), 151.64 (1C, C10a), 151.75 (1C,C10b), 163.87 (1C, C9), 167.76 (1C, C2), 194.21 (1C, CHO). 
ESI-MS: m/z (rel. %): 223.1 (100) (M+H)+, 245.1 (23) (M+Na)+. 
HRMS (ESI): calcd. for [C14H11N2O]+ ([M+H]+): 223.0866, found: 223.0867; calcd. for 












C13H10N2 [194.24]  
 
8-aminoquinoline (2.00 g, 14.0 mmol, 1.00 eq.) and sodium iodide (22 mg, 0.15 mmol) were 
heated at 110 °C in 70% sulfuric acid H2SO4 (3 mL) to allow the complete dissolution of the 
solids. After complete dissolution of the solids, the cratonaldehyde (1.00 mL, 14 mmol, 1.00 eq.) 
was added under nitrogen atmosphere over 5 h at 110 °C, maintaining a continuous stirring. 
After a further hour at 110 °C the black color reaction mixture was allowed to cool at room 
temperature and slowly poured into 1 M sodium carbonate Na2CO3 solution (70 mL) until the 
final pH was around 8. The aqueous solution was extracted with dichloromethane (2 × 40 mL) 
and the combined organic layers were extracted with 37% hydrochloric acid HCl. The acidic 
solution was neutralized by the addition of concentrated sodium hydroxide NaOH solution and 
extracted with dichloromethane (3 × 50 mL). The organic layers were combined and the solvent 
evaporated under reduced pressure. The product was purified by column chromatography on 
silica gel (dichloromethane/methanol, 95:5) and dried over magnesium sulfate affording the 
corresponding 2-methyl-1,10-phenantroline (1.68 g, 8.68 mmol, 62%). 
 
1H-NMR (300 MHz, CDCl3, RT): δ (ppm) = 2.95 (s, 3H, CH3), 7.52 (d, 1H, 3JH,H = 8.2 Hz, H-3), 7.55 
(dd, 1H, 3JH,H = 8.1 Hz, 4.3 Hz, H-8), 7.71-7.80 (m, 2H, H-5, H-6), 8.14 (d, 1H, 3JH,H = 8.1 Hz, H-4), 
8.25 (dd, 1H, 3JH,H = 8.1 Hz, 1.5 Hz, H-7), 9.21 (dd, 1H, JH,H = 4.3 Hz, 1.6 Hz, H-9).  
13C-NMR (126 MHz, CDCl3, RT): δ (ppm) = 37.2 (1C, CH3), 122.65 (1C, C8), 123.65(1C, C3), 125.32 
(1C, C6), 126.37 (1C, C5), 126.54 (1C, C4b), 128.65 (1C, C4a), 136.04 (1C, C7), 136.09 (1C, C4), 
145.7 (1C, C10a), 146.0 (1C, C10b), 150.02 (1C,C9), 159.46 (1C, C2).    
ESI-MS: m/z (rel. %): 195.1 (100) (M+H)+, 411.2 (45) [2M+Na]+. 
HRMS (ESI): calcd. for [C13H11N2]+ ([M+H]+): 195.0917, found: 195.0910; calcd. for [C13H10N2Na]+ 
















The seleniumdioxide (SeO2) (0.60 g, 5.46 mmol, 2.10 eq.) was dissolved in dioxane (19 mL) and 
water (0.5 mL) and heated under reflux. 2-methyl-1,10-phenantroline (0.50 g, 2.60 mmol, 
1.00 eq.) was dissolved in dioxane (12 mL) and added quickly to the refluxing mixture. The 
mixture is refluxed for 15 minutes and then decanted from selenium through filtering it when it 
is hot into a large flask. The solvent was evaporated and the residue was given in water to 
extract it with chloroform. The organic layer was evaporated under reduced pressure and dried 
over Na2SO4 to afford derivative 29 as a brown solid (0.38 g, 1.82 mmol, 70%).   
 
1H NMR (300 MHz, DMSO, RT): δ (ppm) = 7.84 (d, 1H, 3JH,H = 8.1 Hz, H-3), 7.86 (d, 3JH,H = 8.1 Hz, 
1H, H-8), 8.09-8.25 (m, 2H, H-5, H-6), 8.56 (d, 1H, 3JH,H = 8.1 Hz, H-4), 8.71 (dd, JH,H = 8.1 Hz, 1.5 
Hz, 1H, H-7), 9.18 (dd, 1H,  JH,H = 4.3 Hz, 1.6 Hz, H-9),  10.30 (s, 1H, CHO).  
ESI-MS: m/z (rel. %): 223.1 (100) (M+H)+, 209.1 (58) (M+Na). 
HRMS (ESI): calcd. for [C13H9N2O]+ ([M+H]+): 209.0709, found: 209.0711; calcd. for 





















C120H159N41O76P12 [3763.49]  
 
 
HPLC: (DNAPac PA200 4x5mm, DIONEX Ionexchange, Gradient: 25-60% B2 in 30min. [B2 = 
20 mM Tris-Cl, 1.25 M NaCl, pH 8.0, 80° C]): tR = 7.3 min. 















HPLC: (DNAPac PA200 4x5mm, DIONEX Ionexchange, Gradient: 25-60% B2 in 30min. [B2 = 
20 mM Tris-Cl, 1.25 M NaCl, pH 8.0, 80° C]): tR = 9.6 min. 






























HPLC: (DNAPac PA200 4x5mm, DIONEX Ionexchange, Gradient: 25-60% B2 in 30min. [B2 = 
20 mM Tris-Cl, 1.25 M NaCl, pH 8.0, 80° C]): tR = 9.0 min. 















HPLC: (DNAPac PA200 4x5mm, DIONEX Ionexchange, Gradient: 25-60% B2 in 30min. [B2 = 
20 mM Tris-Cl, 1.25 M NaCl, pH 8.0, 80° C]): tR = 9.2 min. 




































HPLC: (DNAPac PA200 4x5mm, DIONEX Ionexchange, Gradient: 25-60% B2 in 30min. [B2 = 
20 mM Tris-Cl, 1.25 M NaCl, pH 8.0, 80° C]): tR = 9.3 min. 















HPLC: (DNAPac PA200 4x5mm, DIONEX Ionexchange, Gradient: 25-60% B2 in 30min. [B2 
= 20 mM Tris-Cl, 1.25 M NaCl, pH 8.0, 80° C]): tR = 5.8 min. 





















A   adenine 
Ac   acetyl 
AcOH   acetic acid 
AE  anion exchange 
approx.  approximately 
aq   aqueous 
ATP   adenosine 5’-triphosphate 
bp   base pair(s) 
br s   broad singlet (NMR assignment) 
Bz  benzoyl 
C   cytosine 
calcd.   calculated 
cat.   catalytic 
conc.   concentrate 
d   doublet (NMR assignment) 
DCC   dynamic combinatorial chemistry  
DCL   dynamic combinatorial library 
DCM   dichloromethane 
dd   doublet of doublets (NMR assignment) 
dATP   2’-deoxyadenosine 5’-triphosphate 
dCTP   2’-deoxycytidine 5’-triphosphate 
dGTP   2’-deoxyguanosine 5’-triphosphate 
DiPEA   N,N-diisopropylethylamine 
DMAP   4-dimethylaminopyridine 
DMF   N,N-dimethylformamide 
DMSO   dimethylsulfoxide 
DNA   2’-deoxyribonucleic acid 
dNTP   2’-deoxynucleotide 5’-triphosphate 
dq   doublet of quartets (NMR assignment) 
dsDNA   double-stranded 2’-deoxyribonucleic acid 
dTTP   2’-deoxythymidine 5’- triphosphate 
EDTA   ethylenediaminetetraacetic acid 
 
 
EI   electron impact 
eq   equivalent(s) 
ES   electrospray 
Et   ethyl 
F   fluorophore 
FA   formic acid 
Fmoc   fluorenylmethoxycarbonyl 
G   guanine 
h   hour(s) 
HPLC   high performance liquid chromatography 
HRMS   high resolution mass spectrometry 
I   relative peak intensity 
J   NMR coupling constant (preceding superscript number denotes 
the number of bonds separating coupled nuclei) 
kb   kilobases (i.e. thousand bases) 
LCMS   liquid chromatography mass spectrometry 
LNA   locked nucleic acid 
m   multiplet (NMR assignment)  
MALDI   matrix-assisted laser desorption/ionization 
Me   methyl 
min   minute(s) 
Mmt   monomethoxytrityl 
mp   melting point 
mRNA   messenger RNA 
MS   mass spectrometry 
m/z   mass-to-charge ratio 
NMR   nuclear magnetic resonance 
nt   nucleotide 
PAGE   polyacrylamide gel electrophoresis 
PBS   phosphate buffered saline 
PCR  polymerase chain reaction 
PEG   polyethylene glycol 
PG   protecting group 




PPi   pyrophosphate 
ppm   parts per million 
q   quartet (NMR assignment) 
RNA   ribonucleic acid 
Rf  thin layer chromatography retention factor (Rf = (distance travelled by analyte) 
/(distance travelled by solvent)) 
rNMP  ribonucleoside monophosphates 
rNTP  ribonucleoside triphosphates 
rRNA   ribosomal RNA 
RT   room temperature 
s  singlet (NMR assignment)  
sat.   saturated 
SNP   single nucleotide polymorphism 
ssDNA   single-stranded 2’-deoxyribonucleic acid 
T   thymine 
t   triplet (NMR assignment) 
TFA   trifluoroacetic acid 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
Tm   duplex melting temperature 
TOF   time-of-flight 
tR   retention time 
Tris   tris(hydroxymethyl)aminomethane 
tRNA   transfer RNA 
U   uracil 
UV   volume/volume ratio 
w/v   weight/volume ratio 
δ   chemical shift 
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